: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription

Articles published in Clin Infect Dis
Retrieve available abstracts of 413 articles:
HTML format

Single Articles

July 2026

JONES T, Lefebvre M, Reyes O, Dalton J, et al
Fever in a Man with Uncontrolled HIV.
Clin Infect Dis. 2026;82:1091-1095.
PubMed

CHAKRAWARTI A, Cromarty RT, Basting CM, Anderson J, et al
Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.
Clin Infect Dis. 2026 Jul 6:ciag369. doi: 10.1093.
PubMed Abstract available

June 2026

SPINELLI M, Heise MJ, Glidden DV, Grochowski J, et al
Virologic Outcomes After LA ART Initiation with and without Viremia in Two Large U.S. Clinic Cohorts.
Clin Infect Dis. 2026 Jun 29:ciag392. doi: 10.1093.
PubMed Abstract available

HORBERG M, Thompson M, Agwu A, Colasanti J, et al
Clarification to HIVMA/IDSA HIV Primary Care Guidance Immunization Recommendations.
Clin Infect Dis. 2026 Jun 24:ciag384. doi: 10.1093.
PubMed

MOHAN G, Hanrahan CF, Martinez-Amezcua P, Hoffmann CJ, et al
Multidimensional Poverty and Implementation Reach of Household Contact Tracing for Tuberculosis in South Africa: Analysis of a Randomized Trial.
Clin Infect Dis. 2026 Jun 17:ciag321. doi: 10.1093.
PubMed Abstract available

ROGG L, Nunez SA, Mingrone MV, Domingo P, et al
Proof-of-Concept Phase 2a Trial of VH4524184 (VH-184), an Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile.
Clin Infect Dis. 2026 Jun 12:ciag357. doi: 10.1093.
PubMed Abstract available

ROBERT-GANGNEUX F, Nevez G, Damiani C, Le Guen Y, et al
Oral Wash PCR Improves the Diagnosis of Pneumocystis Pneumonia in Immunocompromised Patients Without HIV: A Prospective Multicenter Study.
Clin Infect Dis. 2026 Jun 11:ciag356. doi: 10.1093.
PubMed Abstract available

SIDDIQI OK, Jahn B, Rochau U, Walukaga S, et al
Cost-effectiveness Analysis of Xpert MTB/RIF Ultra for the Diagnosis of HIV-Associated Tuberculous Meningitis.
Clin Infect Dis. 2026 Jun 9:ciag348. doi: 10.1093.
PubMed Abstract available

FISAYO T, Evans C, Mutasa K, Alber D, et al
CMV viraemia is associated with mortality among children with HIV starting antiretroviral therapy in sub-Saharan Africa.
Clin Infect Dis. 2026 Jun 9:ciag354. doi: 10.1093.
PubMed Abstract available

ELLIS J, Jarvis JN
Cytomegalovirus viremia in advanced HIV disease.
Clin Infect Dis. 2026 Jun 9:ciag355. doi: 10.1093.
PubMed

KILLANDER MOLLER I, Brannstrom J, Elvstam O, Gisslen M, et al
Renal Risk and Creatinine Elevation in People With HIV - Broadening the Perspective.
Clin Infect Dis. 2026 Jun 2:ciag340. doi: 10.1093.
PubMed

MANESH A, Aslan AT, Mohan George M, Sulaiman H, et al
Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World.
Clin Infect Dis. 2026;82.
PubMed Abstract available

BERENGUER J, Ryan P, Lutz T, Martin-Carbonero L, et al
Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV and Chronic HBV Infection.
Clin Infect Dis. 2026 Jun 1:ciag341. doi: 10.1093.
PubMed Abstract available

May 2026

COGHILL AE, Bender Ignacio R
Further unraveling the association between HIV, immune suppression, and cancer survival.
Clin Infect Dis. 2026 May 29:ciag334. doi: 10.1093.
PubMed

HAAS CB, Shiels MS, Luo Q, Pfeiffer RM, et al
Markers of immune function and survival among cancer patients with HIV in the United States: a population-based registry linkage study.
Clin Infect Dis. 2026 May 29:ciag333. doi: 10.1093.
PubMed Abstract available

FESER M, Maphosa T, Shroufi A, Rangaraj A, et al
Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi.
Clin Infect Dis. 2026 May 28:ciag270. doi: 10.1093.
PubMed Abstract available

BEHUHUMA N, Gasa G, Derache A, Nhlapo B, et al
Efficacy and acceptability of liraglutide for obesity in people with HIV: results of an open-label clinical trial in South Africa.
Clin Infect Dis. 2026 May 28:ciag337. doi: 10.1093.
PubMed Abstract available

LEE TH, Bhattacharya D, Kim HN
Don't Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for Treatment and Prevention of HIV.
Clin Infect Dis. 2026 May 27:ciag322. doi: 10.1093.
PubMed Abstract available

WELD ED, Scott RK
Long-Acting Antiretroviral Therapy to Treat Advanced Human Immunodeficiency Virus in Pregnancy: Let Not Delayed Detection Be the Enemy of the Good.
Clin Infect Dis. 2026 May 25:ciag291. doi: 10.1093.
PubMed

CHIHOTA V, Waggie Z, Cardenas V, Mngadi K, et al
Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial.
Clin Infect Dis. 2026 May 17:ciag315. doi: 10.1093.
PubMed Abstract available

HAZRA A, Chan PA, Clement M, Kaperak CJ, et al
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis.
Clin Infect Dis. 2026 May 15:ciag316. doi: 10.1093.
PubMed Abstract available

BEACH R, Tims-Cook Z, McGary CS, Thote T, et al
Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists.
Clin Infect Dis. 2026;82.
PubMed Abstract available

PARIENTI JJ, Yang SS, Grinspoon S
Selected Industry Highlights From IDWeek 2025.
Clin Infect Dis. 2026;82.
PubMed Abstract available

MOODY K, Vanbellinghen MC, Nieuwkerk PT, Boyd A, et al
Health-related quality of life in well-treated people with HIV and comparators over an 8-year period: a longitudinal analysis from the prospective AGEhIV cohort study.
Clin Infect Dis. 2026 May 14:ciag281. doi: 10.1093.
PubMed Abstract available

SABIN CA
Does HIV infection continue to contribute to poorer health-related quality of life?
Clin Infect Dis. 2026 May 14:ciag282. doi: 10.1093.
PubMed

PUGSLEY RA, Davis NL, Barbee LA
Is one all we really need? Reply to Lorenz et al regarding shorter duration of benzathine penicillin G therapy for late or unknown duration syphilis.
Clin Infect Dis. 2026 May 13:ciag299. doi: 10.1093.
PubMed

FAMIGLIETTI AM, Drammeh S, Vo-Quang E, Dibba B, et al
Field performance and acceptability of the hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) for detecting high viral load among pregnant women in The Gambia (PROTECT-B).
Clin Infect Dis. 2026 May 12:ciag311. doi: 10.1093.
PubMed Abstract available

FONCILLAS A, Ambrosioni J, de la Mora L, Mallolas J, et al
Atypical HBV Serological Patterns After Switching to CAB/RPV: Interpretation Within Current Definitions.
Clin Infect Dis. 2026 May 7:ciag303. doi: 10.1093.
PubMed

ADACHI E, Yotsuyanagi H
Anti-HBs Seroconversion Following Withdrawal of Anti-HBV-Active Agents: An Underrecognized Form of HBV Reactivation?
Clin Infect Dis. 2026 May 7:ciag305. doi: 10.1093.
PubMed

April 2026

LAMB G, Pallett SJC, Charani E, Kanu EM, et al
Assessment of the Prioritization of Diagnostics in National Action Plans for Antimicrobial Resistance.
Clin Infect Dis. 2026 Apr 29:ciag020. doi: 10.1093.
PubMed Abstract available

SHERWOOD K, Zhang N, David H, Dekker A, et al
Missed Opportunities for HIV and Syphilis Co-Testing in Emergency Departments.
Clin Infect Dis. 2026 Apr 28:ciag289. doi: 10.1093.
PubMed

FEITERNA-SPERLING C, Albers E, Rohr I, Weizsacker K, et al
A case of delayed detection of vertical transmission of HIV-1 due to maternal therapy with long-acting injectable cabotegravir plus rilpivirine.
Clin Infect Dis. 2026 Apr 28:ciag290. doi: 10.1093.
PubMed Abstract available

LANDOVITZ RJ, Fogel JM, Gao F, Hanscom B, et al
Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083.
Clin Infect Dis. 2026 Apr 27:ciag285. doi: 10.1093.
PubMed Abstract available

CASILLAS SM, Chida A, Drobeniuc J, Sandul AL, et al
Updated hepatitis D seroprevalence among HBsAg-positive persons aged >/=6 years in the United States, National Health and Nutrition Examination Survey, 2007?2018.
Clin Infect Dis. 2026 Apr 25:ciag274. doi: 10.1093.
PubMed Abstract available

DORWARD J, Masombuka X, Lewis L, Pastellides C, et al
Cardiovascular Disease Risk in Low- and MIddle-income countries: better data for better evidence.
Clin Infect Dis. 2026 Apr 25:ciag280. doi: 10.1093.
PubMed

BAKER JV, Siegel L, Losso M, Vasudeva S, et al
Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial.
Clin Infect Dis. 2026 Apr 22:ciag272. doi: 10.1093.
PubMed Abstract available

PALEFSKY J
Screening for anal cancer in people with HIV- we have the tools to begin.
Clin Infect Dis. 2026 Apr 21:ciag236. doi: 10.1093.
PubMed

KILLANDER MOLLER I, Wagner P, Brannstrom J, Backdahl T, et al
Renal and Cardiovascular Complications Following Type 2 Diabetes Mellitus in People With and Without HIV: Data from Cohort Study on Morbidity and HIV in Sweden (COSMOHS) between 2010-2024.
Clin Infect Dis. 2026 Apr 18:ciag261. doi: 10.1093.
PubMed Abstract available

HERRERO JI, Aguero F, Manzardo C, Gastaca M, et al
De Novo Cancer in Liver Transplant Patients With Human Immunodeficiency Virus Infection: A Multicenter Nationwide Cohort Study.
Clin Infect Dis. 2026 Apr 16:ciag124. doi: 10.1093.
PubMed Abstract available

ZHAN S, Liu W, Yang L, Chen Z, et al
Fixed-Dose Rifapentine-Isoniazid (1HP) for Tuberculosis Preventive Treatment in Chinese Adults: A Prospective Real-World Safety and Pharmacokinetic Study.
Clin Infect Dis. 2026 Apr 13:ciag247. doi: 10.1093.
PubMed Abstract available

HOFFMAN R, Brummel S, Pinilla M, Malonga G, et al
Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV.
Clin Infect Dis. 2026 Apr 13:ciag245. doi: 10.1093.
PubMed Abstract available

BENGTSON A
High levels of elevated blood pressure among pregnant and postpartum women with HIV, regardless of dolutegravir initiation.
Clin Infect Dis. 2026 Apr 13:ciag246. doi: 10.1093.
PubMed

PALUMBO P
You've Come a Long Way Baby-but Many Miles Left to Go.
Clin Infect Dis. 2026 Apr 10:ciag233. doi: 10.1093.
PubMed

WYNCOLL J, Kamolrattana R, Archary M, Mujuru HA, et al
Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial.
Clin Infect Dis. 2026 Apr 10:ciag232. doi: 10.1093.
PubMed Abstract available

FLETCHER FE, Pertuit OR, Troisi C, Kerr J, et al
Tracking HIV Through Wastewater: Ethical Considerations in Public Health Surveillance.
Clin Infect Dis. 2026 Apr 9:ciag241. doi: 10.1093.
PubMed Abstract available

MCGEE-AVILA JK, Haas CB, Shing JZ, Lawrence WR, et al
Hepatocellular Carcinoma Survival in People With and Without HIV in the United States, 2001-2019.
Clin Infect Dis. 2026 Apr 9:ciag137. doi: 10.1093.
PubMed Abstract available

LLIBRE JM, Kuritzkes DR, Martin-Iguacel R, Ripamonti D, et al
Understanding the clinical implications of the barrier against resistance in antiretroviral treatment.
Clin Infect Dis. 2026 Apr 7:ciag226. doi: 10.1093.
PubMed

FONCILLAS A, Ambrosioni J, de la Mora L, Mallolas J, et al
Optimizing HBV Prevention When Switching to Long-Acting Cabotegravir/Rilpivirine.
Clin Infect Dis. 2026 Apr 3:ciag218. doi: 10.1093.
PubMed

ROUGET R, Valin N, Bachelard A, Palacios C, et al
Acute Hepatitis B among PWH Switched to Long-Acting Cabotegravir/Rilpivirine: The Context Matters.
Clin Infect Dis. 2026 Apr 3:ciag217. doi: 10.1093.
PubMed

March 2026

CHIDA N
Staying in the Tent: Why Infectious Disease Physicians Remain Essential to Human Immunodeficiency Virus Primary Care.
Clin Infect Dis. 2026 Mar 27:ciag097. doi: 10.1093.
PubMed Abstract available

GRABER CJ, Landovitz RJ, Branch-Elliman W
Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to Evolve.
Clin Infect Dis. 2026 Mar 27:ciag096. doi: 10.1093.
PubMed Abstract available

MENZA TW, Berzkalns A, Cannon CA, Balkus J, et al
The population-level impact of doxycycline post-exposure prophylaxis on syphilis in King County, WA: an interrupted time series analysis.
Clin Infect Dis. 2026 Mar 26:ciag209. doi: 10.1093.
PubMed Abstract available

MCMANUS KA, Killelea A, Rogers EQ, Liu F, et al
State AIDS Drug Assistance Programs' Contribution to the US Viral Suppression, 2015-2022.
Clin Infect Dis. 2026 Mar 25:ciag034. doi: 10.1093.
PubMed Abstract available

LINAS BP
Centering AIDS Drug Assistance Programs in the US HIV Response.
Clin Infect Dis. 2026 Mar 25:ciag035. doi: 10.1093.
PubMed

SOSSEN B, Martinson N
"Trace-MTB" on Sputum Xpert Ultra: New Evidence for Interpretation in High-burden Settings.
Clin Infect Dis. 2026 Mar 20:ciag018. doi: 10.1093.
PubMed

VISEK C, Dalmat RR, Nalutaaya A, Erisa KC, et al
Prevalence and Predictors of Tuberculosis in Adults and Adolescents With Sputum Trace Ultra Results in 2 High-Burden Clinical Settings.
Clin Infect Dis. 2026 Mar 20:ciag019. doi: 10.1093.
PubMed Abstract available

KOETHE JR, Lake JE, Kantor A, Smeaton L, et al
A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).
Clin Infect Dis. 2026 Mar 18:ciag196. doi: 10.1093.
PubMed Abstract available

CASADO JL, Vizcarra P, Izuzquiza I, Rodriguez-Dominguez MJ, et al
Long-Term Serologic Outcomes Following Treatment of Syphilis in People With HIV: A Prospective Cohort Study.
Clin Infect Dis. 2026 Mar 17:ciag193. doi: 10.1093.
PubMed Abstract available

LANDOVITZ RJ, Pinedo Y, Hinestrosa F, Crofoot GE, et al
Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.
Clin Infect Dis. 2026 Mar 14:ciag171. doi: 10.1093.
PubMed Abstract available

CARSTENS RP, Kapoor Y, Vargo RC, Bhattacharyya A, et al
Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults Living With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From Two Open-Label, Phase 1 St
Clin Infect Dis. 2026 Mar 14:ciag135. doi: 10.1093.
PubMed Abstract available

FURUKAWA NW, Kamili S, Wester C
A Turning Point for Hepatitis C Care: Point-of-Care HCV RNA Authorization as a Critical First Step Towards Integrated Test-and-Treat Models in the United States.
Clin Infect Dis. 2026 Mar 13:ciag174. doi: 10.1093.
PubMed

MARTIN MA, Blenkinsop A, Moffa M, Reynolds SJ, et al
Patterns of HIV-1 viral load suppression and drug resistance during the dolutegravir transition: a population-based longitudinal study.
Clin Infect Dis. 2026 Mar 13:ciag161. doi: 10.1093.
PubMed Abstract available

HILL A, Orkin C
What Are the Causes and Consequences of Virological Failure on Long-acting Cabotegravir/Rilpivirine?
Clin Infect Dis. 2026 Mar 11:ciag047. doi: 10.1093.
PubMed

MAZZITELLI M, Parczewski M, Burger D, Wensing A, et al
Virological Failure on Long-Acting Injectable Cabotegravir and Rilpivirine: An Analysis of Subtypes, Drug Levels, Resistance, and Therapeutic Implications.
Clin Infect Dis. 2026 Mar 11:ciag046. doi: 10.1093.
PubMed Abstract available

MOE CA, Luswata RK, Barrameda AJ, Le H, et al
Diagnostic Yield of Tongue Swab- Compared to Sputum-Based Molecular Testing for Tuberculosis in Four High-Burden Countries.
Clin Infect Dis. 2026 Mar 10:ciag077. doi: 10.1093.
PubMed Abstract available

SCHNEIDER D, Van Bibber NW, Islam JY, Coghill AE, et al
Progression risk in cancer patients with HIV compared to cancer patients without HIV.
Clin Infect Dis. 2026 Mar 9:ciag170. doi: 10.1093.
PubMed Abstract available

YANG E, Van Brantegem P, Peloquin CA, Brooks MB, et al
Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosis.
Clin Infect Dis. 2026 Mar 6:ciag141. doi: 10.1093.
PubMed Abstract available

MACKOW NA, Shao W, Ge L, Komarow L, et al
Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections.
Clin Infect Dis. 2026 Mar 6:ciag160. doi: 10.1093.
PubMed Abstract available

DORWARD J, Masombuka X, Lewis L, Pastellides C, et al
Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa.
Clin Infect Dis. 2026 Mar 4:ciag155. doi: 10.1093.
PubMed Abstract available

LOVEDAY M, Clarence E, Brust JCM, Waitt C, et al
Responding appropriately to safety signals in infants exposed to the 6-month BDLLfx/BDLCfz regimen in utero.
Clin Infect Dis. 2026 Mar 3:ciag143. doi: 10.1093.
PubMed

NELLORE A, Goepfert P, Tan CS, Bajema K, et al
IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19, Influenza, and RSV infections in immunocompromised patients.
Clin Infect Dis. 2026 Mar 2:ciag114. doi: 10.1093.
PubMed Abstract available

February 2026

NELLORE A, Bajema K, Belden K, Blumberg D, et al
IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19 infections in immunocompromised patients.
Clin Infect Dis. 2026 Feb 25:ciag115. doi: 10.1093.
PubMed Abstract available

CRUMPLER M, Realegeno SE, Shakir SM, Hutton SM, et al
Review of the Performance of Laboratory-Based Molecular Diagnostics for Chlamydia trachomatis and Neisseria gonorrhoeae.
Clin Infect Dis. 2026;82.
PubMed Abstract available

MANABE YC, Smith AC, Trow S, Tran A, et al
Point-of-care Tests for Chlamydia trachomatis and Neisseria gonorrhoeae: Review of the Literature.
Clin Infect Dis. 2026;82.
PubMed Abstract available

MITCHELL KK, Smith AC, Ayala JC, Schmerer MW, et al
Review of Methods for Detecting Antimicrobial Resistance of Neisseria gonorrhoeae.
Clin Infect Dis. 2026;82.
PubMed Abstract available

STERKEL AK, Loya TJ, Smith AC, Southern T, et al
Narrative Review of Chlamydia trachomatis Culture, Viability Testing, and Sequencing Methods.
Clin Infect Dis. 2026;82.
PubMed Abstract available

SOGE OO, Reimche JL, Smith AC, Schmerer MW, et al
Culture and Identification of Neisseria gonorrhoeae: A Narrative Review of Current Laboratory Methods.
Clin Infect Dis. 2026;82.
PubMed Abstract available

SMITH AC, Kersh EN
Evidence Review for Centers for Disease Control and Prevention Guidance Development on the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
Clin Infect Dis. 2026;82.
PubMed Abstract available

MOHAREB AM, Boyd A
Hepatitis B Virus Reactivation in People With HIV After Treatment With Non-hepatitis B virus-active Antiretroviral Therapy.
Clin Infect Dis. 2026 Feb 24:ciag002. doi: 10.1093.
PubMed

DENYER RV, Tate JP, Benator DA, Lim JK, et al
Hepatitis B Reactivation in a US Cohort of People With Human Immunodeficiency Virus and Hepatitis B Core Antibody After Switch to Antiretroviral Therapy Without Hepatitis B Activity.
Clin Infect Dis. 2026 Feb 24:ciag001. doi: 10.1093.
PubMed Abstract available

PUGSLEY RA, Davis NL, Cope AB, Diesel JC, et al
Is three really what we need? Relative effectiveness of benzathine penicillin G and doxycycline treatment regimens for late or unknown duration syphilis in 6 United States jurisdictions, 2016-2021.
Clin Infect Dis. 2026 Feb 23:ciag099. doi: 10.1093.
PubMed Abstract available

HERBEL S, Paccoud O, de Montmollin E, Grenier B, et al
Presentation and prognosis of cryptococcosis requiring intensive care unit admission in France: the CRYPTO-ICU study.
Clin Infect Dis. 2026 Feb 18:ciag091. doi: 10.1093.
PubMed Abstract available

RUFFIEUX Y, Andoh J, Haas AD, Chinogurei C, et al
Association of Immunodeficiency and HIV Viremia with Cervical Precancer and Cancer Risk among Women with HIV in South Africa.
Clin Infect Dis. 2026 Feb 14:ciag093. doi: 10.1093.
PubMed Abstract available

BIXLER D, Bennett CC, Yin S, Thomson A, et al
Fatal Overdose, Acute Viral Hepatitis, and Human Immunodeficiency Virus Attributed to Injection Drug Use, Appalachian Region of the United States, 2000-2023.
Clin Infect Dis. 2026 Feb 11:ciaf730. doi: 10.1093.
PubMed Abstract available

GREEN AS, Li JZ, Sax PE
Is Two Drug Therapy with Dolutegravir and Lamivudine an Appropriate Option for People with HIV and Historic Lamivudine Resistance?
Clin Infect Dis. 2026 Feb 10:ciag061. doi: 10.1093.
PubMed

DE LAGARDE M, De Miguel R, Sigcha MA, Blanco JL, et al
Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results from the VOLVER Clinical Trial.
Clin Infect Dis. 2026 Feb 10:ciag060. doi: 10.1093.
PubMed Abstract available

SPINELLI MA, Ewart LD, Ross EJ, Heise MJ, et al
Point-of-Care Urine Tenofovir Drug-Level Feedback Counseling Improves Long-term PrEP Adherence for U.S. MSM in Pilot RCT.
Clin Infect Dis. 2026 Feb 10:ciag080. doi: 10.1093.
PubMed Abstract available

BOLDUC P
Recognizing the Critical Role of ID Physicians in Promoting HIV Syndemic Care in Health Professions Education.
Clin Infect Dis. 2026 Feb 5:ciag068. doi: 10.1093.
PubMed

BALASUBRAMANIAN R, Schnure M, Forster R, Hanage WP, et al
The Potential Effect of Ending CDC Funding for HIV Tests: A Modeling Study in 18 States.
Clin Infect Dis. 2026 Feb 4:ciag038. doi: 10.1093.
PubMed Abstract available

SCOTT SE, Barocas JA
Cutting federal funds for HIV testing means not Ending the HIV Epidemic.
Clin Infect Dis. 2026 Feb 4:ciag039. doi: 10.1093.
PubMed

SOLOVYEVA AV, Volchenkov GV, Ponomarenko OI, Kuznezova TA, et al
Implementing a Program of Comprehensive Tuberculosis Preventive Treatment: Safety, Effectiveness, and Acceptability of Moxifloxacin or Bedaquiline Use for Contacts Exposed to Drug-Resistant Strains.
Clin Infect Dis. 2026 Feb 3:ciaf701. doi: 10.1093.
PubMed Abstract available

January 2026

LOVEDAY M, Clarence E, Hlangu S, Singh N, et al
Pregnant women with MDR/RR-TB and the all-oral 6-month regimen: experiences from a patient series in South Africa.
Clin Infect Dis. 2026 Jan 22:ciag032. doi: 10.1093.
PubMed Abstract available

SWEETSER B, Nguyen H, Dang H, Katumba D, et al
Evaluating the Cepheid Xpert TB/LTBI research-use-only assay for detection of active and latent Mycobacterium tuberculosis infection.
Clin Infect Dis. 2026 Jan 21:ciag005. doi: 10.1093.
PubMed Abstract available

FONCILLAS A, Ambrosioni J, Sempere A, Berrocal L, et al
Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles.
Clin Infect Dis. 2026 Jan 14:ciag023. doi: 10.1093.
PubMed Abstract available

NALUGWA T, Shah KM, Marcelo D, Nakawunde R, et al
Predicted Preferences for Tuberculosis Point-of-Care Tests among Tuberculosis-Affected Individuals in Five High Burden Countries.
Clin Infect Dis. 2026 Jan 14:ciag022. doi: 10.1093.
PubMed Abstract available

DHAND A, Pouch SM
Infections After Kidney Transplantation from Donors with HIV to Recipients with HIV: Insights, Prevention, and the Path Forward.
Clin Infect Dis. 2026 Jan 12:ciaf657. doi: 10.1093.
PubMed

ARANT EC, Davy-Mendez T, Liang T, Rodrigues M, et al
Infections After Kidney Transplantation From Donors With Human Immunodeficiency Virus (HIV) to Recipients With HIV.
Clin Infect Dis. 2026 Jan 12:ciaf656. doi: 10.1093.
PubMed Abstract available

MAKINSON A, Bani-Sadr F, Palich R, Montes B, et al
Switch to BIC/TAF/FTC or DTG + TDF/FTC in virologically suppressed PWH: outcomes in real-world setting with and without tenofovir resistance.
Clin Infect Dis. 2026 Jan 9:ciaf726. doi: 10.1093.
PubMed Abstract available

Correction to: Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
Clin Infect Dis. 2026 Jan 9:ciaf711. doi: 10.1093.
PubMed

SOLOMON SS
When Programs Vanish: The Unseen Consequences.
Clin Infect Dis. 2026 Jan 9:ciaf731. doi: 10.1093.
PubMed

APPA A, Steiner G, Baral S, Riley E, et al
Integrating HIV and Stimulant Use Disorder Treatment: A Pilot Implementation Effectiveness Trial of Contingency Management in HIV Care.
Clin Infect Dis. 2026 Jan 8:ciag006. doi: 10.1093.
PubMed Abstract available

ADAMSON PC, David HM, Pham LQ, Bui HTM, et al
Cefixime for the Treatment of Neisseria gonorrhoeae Infections in a Setting With Increased Antimicrobial Resistance: A Retrospective Study in Hanoi, Vietnam.
Clin Infect Dis. 2026;81.
PubMed Abstract available

FAGAN L, Alexander S, Fifer H
The Invisible Tide of Neisseria gonorrhoeae Treatment Failures: A Review and Commentary.
Clin Infect Dis. 2026;81.
PubMed Abstract available

THU NTM, Brown L, Hawkins O, Bloss K, et al
Development and Clinical Evaluation of a Novel Talaromyces marneffei Mp1p Lateral Flow Assay for Rapid Diagnosis of Talaromycosis.
Clin Infect Dis. 2026 Jan 6:ciag004. doi: 10.1093.
PubMed Abstract available

SURMONT M, Verheyden M, Sahebali S, Goossens M, et al
HPV-Related Anal Precancerous Lesions in MSM: A Comparative Study of PrEP Users and HIV-Positive Individuals.
Clin Infect Dis. 2026 Jan 5:ciaf724. doi: 10.1093.
PubMed Abstract available

OBENG BM, Hutchinson J, Shaik A, Chetchotisakd P, et al
Regional variations of rates and determinants of drug resistance mutations in people failing first-line therapy for HIV-1: a substudy from the D2EFT phase 3b/4 clinical trial.
Clin Infect Dis. 2026 Jan 3:ciaf739. doi: 10.1093.
PubMed Abstract available

December 2025

OSUALA EC, Nkuhairwe IN, Letsoalo MP, Naidoo K, et al
Pharmacokinetics of Twice-Daily Tenofovir Alafenamide In Adults with HIV-Associated TB on BIC/FTC/TAF and Rifampicin.
Clin Infect Dis. 2025 Dec 30:ciaf732. doi: 10.1093.
PubMed Abstract available

IGNACIO RB, Pagkas-Bather J, Gonsalves G, Gianella S, et al
Why Americans are Dying Younger? NIH Is Not the Problem. Our Broken Healthcare Delivery Is.
Clin Infect Dis. 2025 Dec 20:ciaf671. doi: 10.1093.
PubMed Abstract available

MARINO AM, Arua E, de Vos L, Fiphaza K, et al
Hidden in Success: Gendered Patterns of Suboptimal Care Engagement Among TB Patients Who "Successfully" Completed Treatment in South Africa.
Clin Infect Dis. 2025 Dec 19:ciaf714. doi: 10.1093.
PubMed Abstract available

CALDERIN JM, Resendiz-Galvan JE, Abdelgawad N, Davis A, et al
Pharmacokinetics of Dexamethasone in Tuberculous Meningitis.
Clin Infect Dis. 2025 Dec 18:ciaf642. doi: 10.1093.
PubMed Abstract available

TE LINDE E, Wit FWNM, van Welzen BJ, Goorhuis A, et al
Incidence of community-acquired pneumonia and herpes zoster in people with HIV based on CD4-count and age in the current antiretroviral therapy era: a longitudinal cohort study.
Clin Infect Dis. 2025 Dec 18:ciaf686. doi: 10.1093.
PubMed Abstract available

ZHU W, Patel RR, Delaney KP, Huang YA, et al
Simplifying testing for HIV during PrEP Monitoring.
Clin Infect Dis. 2025 Dec 17:ciaf703. doi: 10.1093.
PubMed

SPINELLI MA, Scott HM, Buchbinder SP
The Urgency of Now: Congenital Syphilis in the Doxy-PEP Era.
Clin Infect Dis. 2025 Dec 17:ciaf695. doi: 10.1093.
PubMed

MENDLOWITZ AB, Flemming JA, Kushner T, Wong WWL, et al
Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy.
Clin Infect Dis. 2025 Dec 9:ciaf578. doi: 10.1093.
PubMed Abstract available

MURPHY K, Gromisch M, Connolly J, Wang T, et al
Impact of vaginal estradiol on the genitourinary syndrome of menopause, vaginal microbiome and mucosal immune mediators in women living with HIV.
Clin Infect Dis. 2025 Dec 8:ciaf669. doi: 10.1093.
PubMed Abstract available

November 2025

ERLANDSON KM, Kitch DW, Kantor A, Belaunzaran-Zamudio PF, et al
The Bounce-Back Effect: What Happens After Cessation of Low-Dose Semaglutide in People with HIV.
Clin Infect Dis. 2025 Nov 26:ciaf652. doi: 10.1093.
PubMed Abstract available

KWAGHE VG, Erameh C, Vongdip NG, Edeawe OI, et al
Fulminant Yersinia Pestis Infection in a Known HIV-Positive Patient: A Case Report of Identification in Nigeria 2024.
Clin Infect Dis. 2025;81.
PubMed Abstract available

OLCOTT F, Oddie PD, Barlow MJ, Mamarelis A, et al
Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice.
Clin Infect Dis. 2025 Nov 19:ciaf634. doi: 10.1093.
PubMed Abstract available

VAN SANTEN DK, Chalouni M, Berenguer J, Jarrin I, et al
Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIV.
Clin Infect Dis. 2025 Nov 19:ciaf635. doi: 10.1093.
PubMed Abstract available

MURRILL MT, Velasquez GE, Szumowski JD, Phillips A, et al
Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures.
Clin Infect Dis. 2025 Nov 19:ciaf628. doi: 10.1093.
PubMed Abstract available

MARTINEZ-SANZ J, Garcia-Ruiz de Morales AG, Macias J, Rivero A, et al
Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023.
Clin Infect Dis. 2025 Nov 14:ciaf622. doi: 10.1093.
PubMed Abstract available

ZUGER A
Home testing for contagious illness: Historical context and modern caveats.
Clin Infect Dis. 2025 Nov 14:ciaf623. doi: 10.1093.
PubMed Abstract available

CARRATALA CASTRO L, Munguambe S, Kay A, Ssengooba W, et al
Estimating the Accuracy and Additionality of TB-LAM to Diagnose TB in Children Without HIV (AccuLAM).
Clin Infect Dis. 2025 Nov 10:ciaf525. doi: 10.1093.
PubMed Abstract available

BERCOT B, Assoumou L, Camelena F, Voitichouk C, et al
Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial.
Clin Infect Dis. 2025 Nov 10:ciaf591. doi: 10.1093.
PubMed Abstract available

KENYON C
Screening for anal cancer is associated with real harms and questionable benefits.
Clin Infect Dis. 2025 Nov 8:ciaf613. doi: 10.1093.
PubMed

VAN DER WULP IAJ, Wit FW, Jongen VW, Brinkman K, et al
Earlier initiation of treatment following HIV acquisition reduces non-AIDS-defining malignancy risk.
Clin Infect Dis. 2025 Nov 5:ciaf595. doi: 10.1093.
PubMed Abstract available

CRUM N
Let's Get It Started: Early ART after HIV Acquisition Reduces Non-AIDS-Defining Malignancies.
Clin Infect Dis. 2025 Nov 5:ciaf596. doi: 10.1093.
PubMed

ROLLE C, Achhra A, Harbison C, Finkel D, et al
Combined use of ibalizumab and lenacapavir for the treatment of multidrug-resistant HIV-1: A case series.
Clin Infect Dis. 2025 Nov 3:ciaf597. doi: 10.1093.
PubMed Abstract available

SHORT WR, Ogbuagu OE
New strategies for a vexing problem: injectables to the rescue for people with Multidrug-Resistant HIV.
Clin Infect Dis. 2025 Nov 3:ciaf600. doi: 10.1093.
PubMed

October 2025

PALEFSKY JM, Giuliano AR, Goldstone SE, Dubin B, et al
Anal Human Papillomavirus Infection Progression to Disease Among Men Who Have Sex With Men.
Clin Infect Dis. 2025 Oct 29:ciaf584. doi: 10.1093.
PubMed Abstract available

LOVEDAY M, Hughes J, Mchunu N, Yende-Zuma N, et al
Maternal, pregnancy and infant outcomes in women treated for multidrug/rifampicin-resistant tuberculosis with novel and repurposed drugs in KwaZulu-Natal, South Africa.
Clin Infect Dis. 2025 Oct 29:ciaf593. doi: 10.1093.
PubMed Abstract available

FONG Y, Huang Y, Huang Y, Woo W, et al
Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccine.
Clin Infect Dis. 2025 Oct 25:ciaf558. doi: 10.1093.
PubMed Abstract available

MANABE YC, Hamill MM, Palamountain KM, Achenbach CJ, et al
The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of Human Immunodeficiency Virus Nucleic Acid Assays in the United States.
Clin Infect Dis. 2025 Oct 23:ciaf510. doi: 10.1093.
PubMed Abstract available

MINGCHAY P, Kawkitinarong K, Torvorapanit P, Ohata PJ, et al
Effectiveness of Nebulized Bronchodilator - Enhanced Sputum Induction in Thai Patients with Presumed Pulmonary Tuberculosis; A Randomized Controlled Trial; (NeB-TB Trial).
Clin Infect Dis. 2025 Oct 23:ciaf580. doi: 10.1093.
PubMed Abstract available

PATEL K, Jaramillo-Underwood A, Karalius B, Yao TJ, et al
Integrase Strand Transfer Inhibitors for Treatment-experienced Young Adults With Perinatal HIV in the US: Immunologic, Virologic, and Anthropometric Outcomes.
Clin Infect Dis. 2025 Oct 22:ciaf538. doi: 10.1093.
PubMed Abstract available

LE JN, Zhu W, Huang YA, Wei W, et al
Trends in Persons Prescribed HIV Postexposure Prophylaxis in the United States, 2015-2023.
Clin Infect Dis. 2025 Oct 16:ciaf581. doi: 10.1093.
PubMed Abstract available

ATIEH O, Daher J, Abboud M, Wu Q, et al
Effects of Semaglutide on Cognitive Function in People with HIV: A Randomized Controlled Trial.
Clin Infect Dis. 2025 Oct 16:ciaf577. doi: 10.1093.
PubMed Abstract available

MOONAN PK, Buff A, Nandakumar S, Morris Bamrah S, et al
C-reactive protein in TB meningitis: signal, surrogate, or saboteur?
Clin Infect Dis. 2025 Oct 16:ciaf575. doi: 10.1093.
PubMed

ALLAN-BLITZ LT, Mayer KH
The 2025 Centers for Disease Control and Prevention Non-Occupational HIV Post-Exposure Prophylaxis Guidelines: Updated Regimens and Remaining Questions.
Clin Infect Dis. 2025 Oct 15:ciaf567. doi: 10.1093.
PubMed Abstract available

MULENGA H, Shenje J, Mendelsohn SC, Luabeya AKK, et al
Asymptomatic Tuberculosis in Children with Household Exposure to Mycobacterium tuberculosis.
Clin Infect Dis. 2025 Oct 15:ciaf562. doi: 10.1093.
PubMed Abstract available

LEE YT, Chen SC
Weight Trajectories with Integrase Inhibitors: Unaddressed Insights and Limitations in a Chinese Cohort.
Clin Infect Dis. 2025 Oct 13:ciaf570. doi: 10.1093.
PubMed

AJIBOLA G, Nelson BS, Niesar A, Hong S, et al
Long-term clinical, immunologic, and viral reservoir outcomes in children treated with VRC01LS and 10-1074 monoclonal antibodies in the Tatelo Study.
Clin Infect Dis. 2025 Oct 13:ciaf568. doi: 10.1093.
PubMed Abstract available

BELSHE RB, Bernstein DI, Edwards KM, Frey SE, et al
Vaccine and Treatment Evaluation Units: A Historical Perspective.
Clin Infect Dis. 2025;81.
PubMed Abstract available

DOBRZYNSKI DM, Graciaa DS, Babu TM, Coler RN, et al
From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.
Clin Infect Dis. 2025;81.
PubMed

SERRANO-VILLAR S, Martin-Pedraza L, Tiraboschi J, Novella M, et al
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study).
Clin Infect Dis. 2025 Oct 10:ciaf565. doi: 10.1093.
PubMed Abstract available

TAN B, Krishnaswamy S, MacPhail A, Pilcher D, et al
Role of local and population-based data in Advanced HIV Disease in the ICU.
Clin Infect Dis. 2025 Oct 8:ciaf557. doi: 10.1093.
PubMed

MARTINEZ E, Foncillas A, De la Mora L, Mallolas J, et al
Advanced HIV Disease in the ICU: Experience from a Spanish Cohort.
Clin Infect Dis. 2025 Oct 8:ciaf556. doi: 10.1093.
PubMed

SCHWARTZ EL, Nalintya EK, Skipper CP, Nerima P, et al
Predictive value of C-reactive protein for hospitalization and mortality among people with advanced HIV disease in Uganda receiving the WHO-recommended package of care.
Clin Infect Dis. 2025 Oct 8:ciaf560. doi: 10.1093.
PubMed Abstract available

PANACCIONE S, Jack H, Wurcel A, Rich J, et al
State-of-the-Art Review: The Intersection of Infectious Diseases and Carceral Medicine.
Clin Infect Dis. 2025;81:e42-e51.
PubMed Abstract available

September 2025

MARTINEZ MARTIN P, Esteban-Cantos A, Jurado F, Montejano R, et al
Prognostic value of blood epigenetic biomarkers of aging in persons with well controlled HIV infection.
Clin Infect Dis. 2025 Sep 30:ciaf537. doi: 10.1093.
PubMed Abstract available

DURSTENFELD MS
REPRIEVE Analysis of New Cardiovascular Risk Calculators in HIV: Underpredicting Risk Means Preventing Fewer Heart Attacks.
Clin Infect Dis. 2025 Sep 26:ciaf543. doi: 10.1093.
PubMed

GRINSPOON SK, Zhao S, Martinez E, Fichtenbaum CJ, et al
Risk Assessment in a Global CVD Prevention Cohort of People with HIV by PCE, PREVENT, and SCORE2.
Clin Infect Dis. 2025 Sep 26:ciaf542. doi: 10.1093.
PubMed Abstract available

BOLDUC P, Barakat LA, Sherman EM, Day PG, et al
Promoting Human Immunodeficiency Virus Syndemic Care in Health Professions Education: Linking Workforce Demands to the Aspirations of a Rising Generation.
Clin Infect Dis. 2025 Sep 23:ciaf347. doi: 10.1093.
PubMed Abstract available

LLIBRE JM, Ripamonti D, Geretti AM, Martin-Iguacel R, et al
Emergent Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens.
Clin Infect Dis. 2025 Sep 23:ciaf471. doi: 10.1093.
PubMed Abstract available

LEOCADIO C, Garcia E, Lash M, Berardi J, et al
Clinical Outcomes of Mpox Disease in Patients Treated with Tecovirimat.
Clin Infect Dis. 2025 Sep 19:ciaf520. doi: 10.1093.
PubMed Abstract available

MANN SC, Lykins D, Coyle RP, Witt MD, et al
In the Mismatch: Viral Suppression Despite Low Tenofovir-Diphosphate in Dried Blood Spots in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort.
Clin Infect Dis. 2025 Sep 17:ciaf509. doi: 10.1093.
PubMed Abstract available

MAINARDI I, Gerevini S, Tarantino A, Vercesi R, et al
Changing clinical and laboratory characteristics of Progressive Multifocal Leukoencephalopathy: a retrospective national cohort study.
Clin Infect Dis. 2025 Sep 9:ciaf501. doi: 10.1093.
PubMed Abstract available

BECK IA, Boyce CL, Bishop MD, Oldroyd AR, et al
HIV resistance to dolutegravir varies with co-administered agents.
Clin Infect Dis. 2025 Sep 2:ciaf481. doi: 10.1093.
PubMed Abstract available

BARDA B, Bongiovanni M
Long-acting cabotegravir/rilpivirine in viraemic people with HIV: bumpy raod to perfection.
Clin Infect Dis. 2025 Sep 1:ciaf482. doi: 10.1093.
PubMed

DAVIES SMITH E, Douglas PS, McCallum S, Troendle J, et al
Win ratio aligns with and enhances interpretation of REPRIEVE's primary findings.
Clin Infect Dis. 2025 Sep 1:ciaf477. doi: 10.1093.
PubMed Abstract available

SEIBERT AM, Matheu M, Buckel WR, Bledsoe J, et al
Increasing HIV Testing During Gonorrhea and Chlamydia Evaluations in Urgent Care and Emergency Departments: A Large Health System Initiative.
Clin Infect Dis. 2025 Sep 1:ciaf434. doi: 10.1093.
PubMed Abstract available

August 2025

MAKUZA JD, Jeong D, Law M, Puyat JH, et al
HBV Care Cascade in Rwanda: A Population-based Study From 2016-2023.
Clin Infect Dis. 2025 Aug 29:ciaf393. doi: 10.1093.
PubMed Abstract available

FIGUEROA MI, Brites C, Cecchini D, Ramalho A, et al
Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study.
Clin Infect Dis. 2025 Aug 28:ciaf415. doi: 10.1093.
PubMed Abstract available

WATERS LJ
DOLCE: Sweet Success for Dolutegravir/Lamivudine?
Clin Infect Dis. 2025 Aug 28:ciaf416. doi: 10.1093.
PubMed

POORE H, Wambi P, Nkereuwem E, Nakafeero J, et al
The three-gene Xpert Host Response signature for pediatric tuberculosis screening: A prospective diagnostic accuracy study.
Clin Infect Dis. 2025 Aug 21:ciaf445. doi: 10.1093.
PubMed Abstract available

ZHANG L, Wu X, He Y, Song Y, et al
Impact of different INSTIs on BMI among people living with HIV who newly started ART in Shenzhen, China: a real-world data analysis.
Clin Infect Dis. 2025 Aug 20:ciaf466. doi: 10.1093.
PubMed Abstract available

PARK SY, Takayama C, Ryu J, Sattah M, et al
Design and evaluation of next-generation HIV genotyping for detection of resistance mutations to 28 antiretroviral drugs across five major classes including lenacapavir.
Clin Infect Dis. 2025 Aug 19:ciaf458. doi: 10.1093.
PubMed Abstract available

COBURN SB, Silverberg MJ, Lang R, Lesko C, et al
Clinical predictors and incidence of Kaposi sarcoma among males with HIV in the Treat-all era in the United States and Canada.
Clin Infect Dis. 2025 Aug 18:ciaf446. doi: 10.1093.
PubMed Abstract available

NEANT N, Le MP, Bouchet S, Lagoutte-Renosi J, et al
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With Human Immunodeficiency Virus Type 1: First Results From the ANRS-MIE CARLAPOP Study.
Clin Infect Dis. 2025 Aug 18:ciaf385. doi: 10.1093.
PubMed Abstract available

DAVIS JM, Green E, Solomon DA
A Blurry Line: Navigating Treatment Decisions When the Guidelines Don't Fit.
Clin Infect Dis. 2025 Aug 14:ciaf396. doi: 10.1093.
PubMed

PARIENTI JJ
Background HIV Incidence in PURPOSE 1 and 2 PrEP trials.
Clin Infect Dis. 2025 Aug 14:ciaf436. doi: 10.1093.
PubMed Abstract available

NUTT CT, Lessells RJ, Muyindike WR, Johnson LS, et al
Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries with the Highest Adult HIV Prevalence.
Clin Infect Dis. 2025 Aug 11:ciaf444. doi: 10.1093.
PubMed Abstract available

RUTAKINGIRWA MK, Skipper CP, Dai B, Wele A, et al
Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial.
Clin Infect Dis. 2025 Aug 7:ciaf432. doi: 10.1093.
PubMed Abstract available

RON R, Diaz-Garcia C, Sendagorta E, Cabello-Ubeda A, et al
A Phase IV, open-label, single-arm, multicentric clinical trial for evaluation of Human Papillomavirus 9vHPV vaccine immunogenicity in Men Who Have Sex with Men living with HIV: GeSIDA Study 10017.
Clin Infect Dis. 2025 Aug 6:ciaf435. doi: 10.1093.
PubMed Abstract available

SCHNYDER JL, Haggenburg S, Garcia Garrido HM, Reiners A, et al
Long-term immunogenicity and boostability of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in adults receiving immunosuppressive therapy and adults living with HIV - 3-year follow-up of a pr
Clin Infect Dis. 2025 Aug 6:ciaf438. doi: 10.1093.
PubMed Abstract available

PEI PP, Jones M, Hu R, Chen W, et al
Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US.
Clin Infect Dis. 2025 Aug 4:ciaf428. doi: 10.1093.
PubMed Abstract available

DRUMEL T, Sourice J, Allavena C, Rodallec A, et al
Kinetics of non-nucleoside reverse transcriptase inhibitor resistance-associated mutations in HIV-1 proviral cellular reservoirs in NNRTI-experienced persons.
Clin Infect Dis. 2025 Aug 4:ciaf430. doi: 10.1093.
PubMed Abstract available

GIACOMELLI A, Capra N, Lolatto R, Gagliardini R, et al
All-Cause Mortality in People with Four-Class Drug-Resistant HIV: A Matched Cohort Analysis with Data from the PRESTIGIO Registry.
Clin Infect Dis. 2025 Aug 1:ciaf421. doi: 10.1093.
PubMed Abstract available

COLASANTI JA, Aldredge A, Niles-Carnes LV, Ochieng E, et al
Long-acting cabotegravir/rilpivirine, lenacapavir, and ibalizumab use among persons with HIV-1 viremia at a Ryan White-funded clinic in the urban U.S. South.
Clin Infect Dis. 2025 Aug 1:ciaf425. doi: 10.1093.
PubMed Abstract available

July 2025

WIRDEN M, Guihot A, Gautheret-Dejean A, Sterlin D, et al
Consequences of stopping antiretroviral treatment in a persistently seronegative individual infected with HIV-1.
Clin Infect Dis. 2025 Jul 31:ciaf422. doi: 10.1093.
PubMed Abstract available

KIM AY, Kang M, Umbleja T, Nunes EP, et al
Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C.
Clin Infect Dis. 2025 Jul 30:ciaf305. doi: 10.1093.
PubMed Abstract available

BERENGUER J, Fanciulli C, Arcos MM, Vivancos MJ, et al
Trends in HCV Infection Prevalence Among People with HIV in Spain Over Two Decades (2002-2023).
Clin Infect Dis. 2025 Jul 24:ciaf407. doi: 10.1093.
PubMed Abstract available

BEZUIDENHOUT C, Long L, Nichols B, Meyer-Rath G, et al
Sputum and tongue swab molecular testing for the in-home diagnosis of tuberculosis in unselected household contacts: a cost and cost-effectiveness analysis.
Clin Infect Dis. 2025 Jul 24:ciaf389. doi: 10.1093.
PubMed Abstract available

CHISSUMBA RM, Kwatra G, Ramgi P, Enosse M, et al
Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine.
Clin Infect Dis. 2025;80.
PubMed Abstract available

DE SCHACHT C, Capitine IU, Lucas C, Muteerwa A, et al
Importance of Targeted Communication Strategies During COVID-19 Vaccination Campaigns in Mozambique: Results of a Mixed-Methods Acceptability Study.
Clin Infect Dis. 2025;80.
PubMed Abstract available

STREINU-CERCEL A, Castagna A, Chang SC, Chen YS, et al
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients with COVID-19 (BIRCH): a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.
Clin Infect Dis. 2025 Jul 22:ciaf406. doi: 10.1093.
PubMed Abstract available

ROCKMAN L, Abdulgader SM, Minnies S, Palmer Z, et al
Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputum.
Clin Infect Dis. 2025 Jul 18:ciaf397. doi: 10.1093.
PubMed Abstract available

ANDREWS HS, Murthy M, Davis BT
State-of-the-Art Review: Anal Cancer Screening in People With HIV.
Clin Infect Dis. 2025;80:e80-e88.
PubMed Abstract available

ANDREWS HS, Murthy M, Davis BT
Executive Summary: State-of-the-Art Review: Anal Cancer Screening in People With HIV.
Clin Infect Dis. 2025;80:1177-1178.
PubMed

SCHOEPF IC, Baltisberger V, Thorball CW, Ryom L, et al
Low Trauma Fractures in People with HIV: Longitudinal Time Trends in the Swiss HIV Cohort Study 2009-2022.
Clin Infect Dis. 2025 Jul 17:ciaf392. doi: 10.1093.
PubMed Abstract available

LITTLE JS, Edelstein GE, Swank Z, Choudhary MC, et al
Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic andiral Characteristics and Response to Dual and Extended Antiviral Therapy.
Clin Infect Dis. 2025 Jul 16:ciaf383. doi: 10.1093.
PubMed Abstract available

TAIWO BO, Zheng Y, Rodriguez K, Burke L, et al
Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults with HIV-1: ACTG A5357.
Clin Infect Dis. 2025 Jul 15:ciaf375. doi: 10.1093.
PubMed Abstract available

ZHU L, Furukawa NW, Thompson WW, Reitsma MB, et al
Potential impact of frequent testing for hepatitis C virus among people who inject drugs toward hepatitis C elimination in the United States.
Clin Infect Dis. 2025 Jul 15:ciaf368. doi: 10.1093.
PubMed Abstract available

TAN B, Webster H, Krishnaswamy S, MacPhail A, et al
Outcomes of critical illness in peoples with Advanced HIV Disease: 30 years of binational data.
Clin Infect Dis. 2025 Jul 4:ciaf362. doi: 10.1093.
PubMed Abstract available

BROWN TT, Arao RF, Warsi M, Phanuphak N, et al
Bone Changes With Long-Acting Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention in Cisgender Men and Transgender Women: HPTN 083.
Clin Infect Dis. 2025 Jul 1:ciaf221. doi: 10.1093.
PubMed Abstract available

June 2025

NYEIN PP, Borok M, Eriobu N, Kaplan R, et al
A randomised trial to compare dolutegravir plus boosted darunavir versus recommended standard of care antiretroviral regimens in people with HIV-1, whose first-line non-nucleoside reverse transcriptase inhibitor therapy has failed: Final 96-week resul
Clin Infect Dis. 2025 Jun 27:ciaf346. doi: 10.1093.
PubMed Abstract available

COLLINS LF, Christopoulos KA, McNulty MC, Colasanti JA, et al
Comparing interest in thigh administration of long-acting cabotegravir/rilpivirine among hypothetical users, early adopters and trial participants with experience.
Clin Infect Dis. 2025 Jun 25:ciaf333. doi: 10.1093.
PubMed

TUGUME L, Cresswell FV, Engen NW, Tukundane A, et al
Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study.
Clin Infect Dis. 2025 Jun 24:ciaf261. doi: 10.1093.
PubMed Abstract available

PATAMATAMKUL S
Should ART Be Interrupted in Recently Initiated Persons With Recently Diagnosed HIV-Associated Cryptococcal Meningitis?
Clin Infect Dis. 2025 Jun 24:ciaf226. doi: 10.1093.
PubMed

VAN ZYL GU, Decloedt E, Jennings L, Kellermann T, et al
A real-time urine tenofovir assay improves drug adherence among people with HIV with prior virologic failure in a randomized controlled trial.
Clin Infect Dis. 2025 Jun 20:ciaf337. doi: 10.1093.
PubMed Abstract available

CORLEY MJ, Watanabe M, Pang APS, Dwaraka VB, et al
Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial.
Clin Infect Dis. 2025 Jun 18:ciaf247. doi: 10.1093.
PubMed Abstract available

LU X, Jiang Y, Zhang R, Zhang Y, et al
Epidemiologic and Bacterial Factors Facilitating Long-Term Transmission of Multidrug-Resistant Tuberculosis in Shanghai, China.
Clin Infect Dis. 2025 Jun 18:ciaf313. doi: 10.1093.
PubMed Abstract available

AGARWAL R, Nyendak M, Chava N, Allam RR, et al
Long-term protection from TB preventive treatment among people with HIV in a high-burden tuberculosis setting: an observational cohort study from India.
Clin Infect Dis. 2025 Jun 16:ciaf322. doi: 10.1093.
PubMed Abstract available

SHAPIRO L, Henao-Martinez AF
Letter to the Editor: Re-evaluating Immune-Based Strategies for Cryptococcal Meningitis in Non-HIV Populations.
Clin Infect Dis. 2025 Jun 16:ciaf326. doi: 10.1093.
PubMed

HAW NJL, Lesko CR, Ng DK, Lam JO, et al
Incidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022.
Clin Infect Dis. 2025 Jun 5:ciaf300. doi: 10.1093.
PubMed Abstract available

JAGANATH D, Nabeta P, Nicol MP, Castro R, et al
Stool processing methods for Xpert Ultra testing in childhood tuberculosis: A prospective, multi-country accuracy study.
Clin Infect Dis. 2025 Jun 3:ciaf289. doi: 10.1093.
PubMed Abstract available

CROWELL TA, Hsieh HC, Agan BK
New Data and Next Steps for Clarifying how the Timing of Antiretroviral Therapy Initiation Influences Viral Blips and HIV Reservoir Size.
Clin Infect Dis. 2025 Jun 3:ciaf273. doi: 10.1093.
PubMed

May 2025

AUDSLEY J, Avihingsanon A, Li X, Edwards R, et al
Kinetics and predictors of Hepatitis B surface antigen (HBsAg) loss after commencing HBV-active antiretroviral therapy (ART) in the setting of HIV-and chronic HBV co-infection.
Clin Infect Dis. 2025 May 31:ciaf281. doi: 10.1093.
PubMed Abstract available

PURCHASE SE, Brigden J, Seddon JA, Martinson NA, et al
Risk of tuberculosis infection in young children exposed to multidrug-resistant tuberculosis in the TB-CHAMP multi-site randomised controlled trial.
Clin Infect Dis. 2025 May 29:ciaf284. doi: 10.1093.
PubMed Abstract available

ANDREWS HS, Blanchard HL, Yang S, Utay NS, et al
Low Rate of Documented Measles Immunity in a Large Urban HIV Clinic.
Clin Infect Dis. 2025 May 28:ciaf278. doi: 10.1093.
PubMed Abstract available

HALL EW, Sandul AL, Kamili S, Cartwright EJ, et al
Cost-Effectiveness Analysis of Testing Approaches for Diagnosis of Hepatitis C Among US Adults.
Clin Infect Dis. 2025 May 21:ciaf166. doi: 10.1093.
PubMed Abstract available

LOOSLI T, Moore CB, Buzaalirwa L, Byakwaga H, et al
Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study.
Clin Infect Dis. 2025 May 20:ciaf204. doi: 10.1093.
PubMed Abstract available

STURNY-LECLERE A, Francoise U, Badje AD, Garcia-Hermoso D, et al
Histoplasma antigenuria prevalence in patients with advanced HIV disease in Cote d'Ivoire: a prospective trial ancillary study.
Clin Infect Dis. 2025 May 16:ciaf237. doi: 10.1093.
PubMed Abstract available

ODEYEMI Y, Tekin A, Schanz C, Schreier D, et al
Comparative effectiveness of azithromycin versus doxycycline in hospitalized patients with community acquired pneumonia treated with beta-lactams: A multicenter matched cohort study.
Clin Infect Dis. 2025 May 16:ciaf252. doi: 10.1093.
PubMed Abstract available

HAN WM, Ryom L, Sabin CA, Greenberg L, et al
Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohort.
Clin Infect Dis. 2025 May 15:ciaf248. doi: 10.1093.
PubMed Abstract available

SCHWARTZ IS, Pasqualotto AC
Histoplasma antigen screening in advanced HIV disease.
Clin Infect Dis. 2025 May 13:ciaf238. doi: 10.1093.
PubMed

KONOPNICKI D, Gilles C, Manigart Y, Barlow P, et al
Immunogenicity and safety of two versus three doses of 9-valent vaccine against Human papillomavirus (HPV) in women with HIV: the Papillon randomized trial.
Clin Infect Dis. 2025 May 13:ciaf241. doi: 10.1093.
PubMed Abstract available

HAWKINS KL, Dandachi D, Verzani Z, Brannock MD, et al
HIV Infection and Long COVID: A RECOVER Program, Electronic Health Record Based Cohort Study.
Clin Infect Dis. 2025 May 12:ciaf242. doi: 10.1093.
PubMed Abstract available

STADLER JAM, Kuhlin JJ, Molloy SF, Mtwa NN, et al
Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
Clin Infect Dis. 2025 May 9:ciaf112. doi: 10.1093.
PubMed Abstract available

SPINELLI MA, Heise MJ, Roman J, Bena J, et al
Sustained Effectiveness of Doxycycline Post-Exposure-Prophylaxis in a Large Sexual Health Clinic over 96 Weeks: An Interrupted Time Series Analysis.
Clin Infect Dis. 2025 May 6:ciaf234. doi: 10.1093.
PubMed Abstract available

NAMBIAR P, Liang T, Labo N, Hand J, et al
Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients with HIV in the United States.
Clin Infect Dis. 2025 May 5:ciaf229. doi: 10.1093.
PubMed Abstract available

ZHU W, Delaney K, Huang YA, Patel RR, et al
HIV RNA testing to monitor oral PrEP use does not add clinical value: a real-world cohort study-United States, 2019-2023.
Clin Infect Dis. 2025 May 5:ciaf230. doi: 10.1093.
PubMed Abstract available

April 2025

OMBAJO LA, Penner J, Nkuranga J, Omodi V, et al
Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir Trial.
Clin Infect Dis. 2025;80:889-892.
PubMed Abstract available

HAO J, Liu X, Wang D, Hu H, et al
Transmitted Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance Among Newly Diagnosed Individuals in 31 Provincial-Level Administrative Divisions in China in 2023: A Cross-sectional Survey.
Clin Infect Dis. 2025 Apr 29:ciaf159. doi: 10.1093.
PubMed Abstract available

LARSSON L, Calderwood CJ, Marambire ET, Held K, et al
Body mass index trajectories and association with tuberculosis risk in a cohort of household contacts in Southern Africa.
Clin Infect Dis. 2025 Apr 28:ciaf222. doi: 10.1093.
PubMed Abstract available

GRINSPOON SK, Watanabe M, Ribaudo HJ, Bloomfield GS, et al
Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIV.
Clin Infect Dis. 2025 Apr 25:ciaf210. doi: 10.1093.
PubMed Abstract available

KRISHNAN S, Scully EP
Untangling the Sources of HIV-related Cardiovascular Risk.
Clin Infect Dis. 2025 Apr 25:ciaf211. doi: 10.1093.
PubMed

YOON H, Pirofski LA, Boulware DR
Cryptococcal Meningitis Treatment Beyond HIV: Recognizing the need for Individualized Immune-Based Strategies.
Clin Infect Dis. 2025 Apr 25:ciaf218. doi: 10.1093.
PubMed Abstract available

KIM S, Pelissari DM, Harada LO, Sanchez M, et al
Long-term mortality trends among individuals with tuberculosis: a retrospective cohort study of individuals diagnosed with tuberculosis in Brazil.
Clin Infect Dis. 2025 Apr 18:ciaf206. doi: 10.1093.
PubMed Abstract available

BREGER TL, Westreich DJ, Edmonds A, Edwards JK, et al
Incidence of statin initiation among people with and without HIV in the US: a prospective observational study.
Clin Infect Dis. 2025 Apr 17:ciaf207. doi: 10.1093.
PubMed Abstract available

MONTEPIEDRA G, Aaron L, Theron G, McCarthy K, et al
Hepatotoxicity Among People Living with HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics.
Clin Infect Dis. 2025 Apr 16:ciaf198. doi: 10.1093.
PubMed Abstract available

KULIK GL, Mollner DC, Barbera L, Walker J, et al
Application of Pragmatic Criteria to Assessments of Frailty and Physical Function among People with HIV.
Clin Infect Dis. 2025 Apr 15:ciaf193. doi: 10.1093.
PubMed Abstract available

SCOTT K, O'Rourke J, Jackson C, Ene L, et al
Viral suppression, viral failure and safety outcomes in children and adolescents living with HIV on dolutegravir in Europe and Thailand.
Clin Infect Dis. 2025 Apr 11:ciaf191. doi: 10.1093.
PubMed Abstract available

BAETEN JM
Lenacapavir for Human Immunodeficiency Virus (HIV) Prevention: A Commitment to Equitable Access and Partnership by Gilead Sciences.
Clin Infect Dis. 2025 Apr 9:ciaf116. doi: 10.1093.
PubMed Abstract available

HILL A, Siedner MJ, Fairhead C, Venter F, et al
The Need for Lenacapavir Compulsory Licences in Ending the HIV Epidemic.
Clin Infect Dis. 2025 Apr 9:ciaf115. doi: 10.1093.
PubMed Abstract available

TOY M, Hutton D, Teshale E, Thompson WW, et al
Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults living with Chronic Hepatitis B in the United States.
Clin Infect Dis. 2025 Apr 8:ciaf181. doi: 10.1093.
PubMed Abstract available

RIVERA-VILLEGAS H, Caro-Vega Y, Trujillo-Gamboa A, Lopez-Iniguez A, et al
Differences in mortality in hospitalized advanced HIV disease between treatment-naive and treatment-discontinuing individuals: a comparative retrospective study from Mexico City.
Clin Infect Dis. 2025 Apr 3:ciaf175. doi: 10.1093.
PubMed Abstract available

ZHU W, Delaney K, Huang YA, Patel RR, et al
Real-world HIV RNA and antigen/antibody testing among people who use long-acting injectable PrEP.
Clin Infect Dis. 2025 Apr 3:ciaf173. doi: 10.1093.
PubMed Abstract available

WENSING AM, Charpentier C, Calvez V, Ceccherini-Silberstein F, et al
Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance.
Clin Infect Dis. 2025 Apr 3:ciaf161. doi: 10.1093.
PubMed Abstract available

DAVY-MENDEZ T, Napravnik S, Hogan BC, Eron JJ, et al
Changes in the prevalence of non-AIDS conditions among hospitalized persons with HIV in the United States and Canada, 2008-2018.
Clin Infect Dis. 2025 Apr 2:ciaf167. doi: 10.1093.
PubMed Abstract available

STEAD D, Wasserman S, Steenkamp E, Parrish A, et al
Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra for Diagnosing Tuberculosis in Adult Inpatients With Human Immunodeficiency Virus in East London, South Africa.
Clin Infect Dis. 2025 Apr 2:ciaf080. doi: 10.1093.
PubMed Abstract available

March 2025

GUARALDI G, Milic J
A Metabolic Health Framework to Interpret Weight Gain Studies in People With Human Immunodeficiency Virus.
Clin Infect Dis. 2025 Mar 28:ciae646. doi: 10.1093.
PubMed

GARCIA-RUIZ DE MORALES AG, Suarez Robles M, Perez-Elias MJ, Negredo E, et al
Metabolic Complications After Initiating BIC/FTC/TAF Versus DTG + 3TC in ART-naive Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study.
Clin Infect Dis. 2025 Mar 28:ciae645. doi: 10.1093.
PubMed Abstract available

PEREZ-VALERO I, Mata DC, Espejo AC, Gallo M, et al
Real-world effectiveness and safety of BIC/FTC/TAF in comparison with other regimens in people with HIV starting therapy with AIDS-defining conditions. Results from the CORIS Cohort: The ACTUAS II Study.
Clin Infect Dis. 2025 Mar 27:ciaf162. doi: 10.1093.
PubMed Abstract available

BARTL L, Zeeb M, Kalin M, Loosli T, et al
Machine Learning-Based Prediction of Active Tuberculosis in People with HIV using Clinical Data.
Clin Infect Dis. 2025 Mar 25:ciaf149. doi: 10.1093.
PubMed Abstract available

ADZEMOVIC T, Nalintya E, Fieberg A, Mande E, et al
Diagnostic Accuracy of the Updated FujiLAM II Assay to Detect Tuberculosis in Outpatients With Advanced HIV Disease.
Clin Infect Dis. 2025 Mar 25:ciaf079. doi: 10.1093.
PubMed Abstract available

MEYEROWITZ EA, Schwartz IS
Silence=Death Redux: Infectious Diseases, Public Health, and the Imperative to Resist.
Clin Infect Dis. 2025 Mar 24:ciaf155. doi: 10.1093.
PubMed Abstract available

CUELLA-MARTIN I, Hakizayezu F, Ahmed A, Runyambo D, et al
Paucibacillary tuberculosis drives the low positive predictive value of Xpert MTB/RIF Ultra for rifampicin resistance detection in low-prevalence settings.
Clin Infect Dis. 2025 Mar 22:ciaf132. doi: 10.1093.
PubMed Abstract available

ROGG L, Underwood M, Hanan N, Castillo-Mancilla JR, et al
Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile.
Clin Infect Dis. 2025 Mar 21:ciaf135. doi: 10.1093.
PubMed Abstract available

SODEKE O, Shah NS, Pals S, Riabokon S, et al
Lower Tuberculosis Incidence Among People With Human Immunodeficiency Virus Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: A Retrospective Cohort Study.
Clin Infect Dis. 2025 Mar 18:ciaf069. doi: 10.1093.
PubMed Abstract available

MATOGA MM, Chen JS, Sena AC, Ndalama B, et al
High prevalence of Haemophilus ducreyi among patients with suspected primary syphilis in Malawi, 2019-2022.
Clin Infect Dis. 2025 Mar 17:ciaf114. doi: 10.1093.
PubMed Abstract available

HASTIE E, Hill L, Bamford L, Karim A, et al
Long-acting injectable HIV therapy outcomes among persons with HIV who have adherence challenges to oral antiretroviral therapy.
Clin Infect Dis. 2025 Mar 17:ciaf120. doi: 10.1093.
PubMed Abstract available

ROCKSTROH JK, Paredes R, Cahn P, Molina JM, et al
Doravirine/islatravir (100/0.75 mg) once-daily compared to bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment: 48-week results from a phase 3, randomized, controlled, double-blind, non-inferiority trial.
Clin Infect Dis. 2025 Mar 13:ciaf077. doi: 10.1093.
PubMed Abstract available

CHARPENTIER C, Berzow D, Le Hingrat Q, Kaiser R, et al
HIV-2EU - Supporting Standardized HIV-2 Drug Resistance Interpretation: an Update.
Clin Infect Dis. 2025 Mar 12:ciaf110. doi: 10.1093.
PubMed Abstract available

VELAPHI S, Madewell ZJ, Tippett-Barr B, Blau DM, et al
Investigating the role of cytomegalovirus as a cause of stillbirths and child deaths in low and middle-income countries through postmortem minimally invasive tissue sampling.
Clin Infect Dis. 2025 Mar 10:ciaf098. doi: 10.1093.
PubMed Abstract available

CROWELL TA, Hsieh HC, Wang X, Chu X, et al
Antiretroviral Therapy within Two Years of HIV Acquisition is Associated with Fewer Viral Blips: A Retrospective Analysis of Over 20 Years of Data from the U.S. Military HIV Natural History Study.
Clin Infect Dis. 2025 Mar 10:ciaf103. doi: 10.1093.
PubMed Abstract available

DE MIGUEL R, de Lagarde Sebastian M, Blanco Arevalo JL, Pinto-Martinez A, et al
Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons with Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicentre, Phase IIA Clinical Trial.
Clin Infect Dis. 2025 Mar 7:ciaf100. doi: 10.1093.
PubMed Abstract available

February 2025

SOGE OO, Thibault CS, Cannon CA, McLaughlin SE, et al
Potential Impact of Doxycycline Post-Exposure Prophylaxis on Tetracycline Resistance in Neisseria gonorrhoeae and Colonization with Tetracycline-Resistant Staphylococcus aureus and Group A Streptococcus.
Clin Infect Dis. 2025 Feb 28:ciaf089. doi: 10.1093.
PubMed Abstract available

BURGOS J, Curran A, Garcia J, Campany D, et al
Effectiveness of electrocautery, topical cidofovir and topical sinecatechins for the Treatment of Anal High-grade Squamous Intraepithelial Lesions in Persons with HIV: an open-label, randomized controlled trial.
Clin Infect Dis. 2025 Feb 27:ciaf086. doi: 10.1093.
PubMed Abstract available

SWARTWOOD NA, Cohen T, Marks SM, Hill AN, et al
Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis.
Clin Infect Dis. 2025 Feb 27:ciaf092. doi: 10.1093.
PubMed Abstract available

VAN SICKELS N, Wong JWH, Villacorta-Cari E, Lee SE, et al
State-of-the-Art Review: Data and Trust to Improve Care for Transgender and Gender-Diverse Patients.
Clin Infect Dis. 2025;80:e16-e30.
PubMed Abstract available

OKUMURA N, Morino E, Nomoto H, Yanagi M, et al
LC16m8 for Pre-exposure Prophylaxis against Mpox in a High-Risk Population: An Open-Label Randomized Trial.
Clin Infect Dis. 2025 Feb 21:ciaf074. doi: 10.1093.
PubMed Abstract available

TZELIOS CA, Malatesta S, Carney T, White LF, et al
Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis.
Clin Infect Dis. 2025 Feb 20:ciae642. doi: 10.1093.
PubMed Abstract available

LUETKEMEYER AF, Chew KW, Lacey S, Hughes MD, et al
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.
Clin Infect Dis. 2025 Feb 17:ciaf029. doi: 10.1093.
PubMed Abstract available

SAKURAI A, Ishikane M, Ohmagari N
The Importance of Stratifying by Extremely Low CD4 Counts and Assessing Detailed Clinical Information for Clear Outcome Measures.
Clin Infect Dis. 2025 Feb 7:ciaf058. doi: 10.1093.
PubMed

BENDER IGNACIO R, Kitahata M, Montano M, Shapiro A, et al
Mpox in People with HIV: Prioritizing Interventions for those without HIV Viral Suppression.
Clin Infect Dis. 2025 Feb 7:ciaf059. doi: 10.1093.
PubMed

TROYA J, Montes ML, Losa JE, Buzon-Martin L, et al
Long-Acting CAB Plus RPV: It's Not About Weight, It's About the Weight of the Evidence.
Clin Infect Dis. 2025 Feb 5:ciaf024. doi: 10.1093.
PubMed

COLLIER M, Chouchana L, Frange P, Sibiude J, et al
Risk of Neurodevelopmental Disorders in Children Exposed to Human Immunodeficiency Virus and Antiretrovirals In Utero: A National Cohort Study in France.
Clin Infect Dis. 2025 Feb 5:ciae610. doi: 10.1093.
PubMed Abstract available

GAISA M, Deshmukh A, Sigel K, Liu Y, et al
2024 Anal Cancer Screening Guidelines: Analysis of Clinical Performance and HRA Utilization in a large Cohort of Persons with HIV.
Clin Infect Dis. 2025 Feb 3:ciaf052. doi: 10.1093.
PubMed Abstract available

YU MA, Gerig L, Mehta CC, Musonge-Effoe J, et al
Non-invasive markers of hepatic steatosis and fibrosis following INSTI initiation in women with HIV.
Clin Infect Dis. 2025 Feb 3:ciaf049. doi: 10.1093.
PubMed Abstract available

January 2025

GRENNAN T, Mohammed S, Edward J, Tattersall T, et al
A pilot, randomized controlled trial of Dual Daily HIV and sexually transmitted infection pre-exposure prophylaxis using tenofovir disoproxil fumarate/emtricitabine and doxycycline in gay, bisexual and other men who have sex with men and transgender w
Clin Infect Dis. 2025 Jan 30:ciaf043. doi: 10.1093.
PubMed Abstract available

BILIR SP, Krishnamurthy P, Karichu JK, Blosser SJ, et al
Estimating the economic consequences of leveraging the novel cobas(R) HIV-1/HIV-2 Qualitative NAT Test in routine HIV testing.
Clin Infect Dis. 2025 Jan 29:ciaf025. doi: 10.1093.
PubMed Abstract available

CHEMALY RF, Shafat T, Wald A, Kotton CN, et al
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials.
Clin Infect Dis. 2025 Jan 29:ciae638. doi: 10.1093.
PubMed Abstract available

FORD SL, Felizarta F, Han K, Wang K, et al
Thigh Injections of Cabotegravir + Rilpivirine in Virally Suppressed Adults With Human Immunodeficiency Virus Type 1: A Substudy of the Phase 3b ATLAS-2M Study.
Clin Infect Dis. 2025 Jan 29:ciae620. doi: 10.1093.
PubMed Abstract available

BANOONI P, Gonik B, Epalza C, Reyes O, et al
Efficacy, immunogenicity, and safety of an investigational maternal respiratory syncytial virus prefusion F protein-based vaccine.
Clin Infect Dis. 2025 Jan 29:ciaf033. doi: 10.1093.
PubMed Abstract available

MARCUS JL, Weddle A, Kelley CF, Agwu A, et al
Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
Clin Infect Dis. 2025 Jan 28:ciae648. doi: 10.1093.
PubMed Abstract available

WONDMENEH S, McDonald R, Quilter LAS, Workowski K, et al
Reported Neurologic Manifestations Among Persons with Syphilis by Stage of Infection-12 States, 2019 -2022.
Clin Infect Dis. 2025 Jan 17:ciaf015. doi: 10.1093.
PubMed Abstract available

KNUDSEN AD, Fuchs A, Benfield T, Kober L, et al
HIV Is Associated With Subclinical Coronary Atherosclerosis: A Prospective Matched Cohort Study.
Clin Infect Dis. 2025 Jan 16:ciae609. doi: 10.1093.
PubMed Abstract available

BARRE T, Ramier C, Wittkop L, Sogni P, et al
Low CD4 cell count is associated with post-hepatitis C virus cure mortality in people living with HIV (ANRS CO13 HEPAVIH cohort).
Clin Infect Dis. 2025 Jan 15:ciaf016. doi: 10.1093.
PubMed

MOYO M, Lawrence DS, Jafali J, Molloy SF, et al
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in Human Immunodeficiency Virus-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From Africa.
Clin Infect Dis. 2025 Jan 15:ciae586. doi: 10.1093.
PubMed Abstract available

MATELSKI A, Gregoire B, Beste LA, Varley CD, et al
Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a Large Cohort of U.S. Veterans.
Clin Infect Dis. 2025 Jan 9:ciaf008. doi: 10.1093.
PubMed Abstract available

Correction to: Prediction of HIV Drug Resistance Based on Virologic, Immunologic, Clinical, and/or Adherence Criteria in the Stratall ANRS 12110/ESTHER Trial in Cameroon.
Clin Infect Dis. 2025 Jan 7:ciaf001. doi: 10.1093.
PubMed

CHUNG JR, Price AM, Zimmerman RK, Moehling Geffel K, et al
Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 season.
Clin Infect Dis. 2025 Jan 6:ciae658. doi: 10.1093.
PubMed Abstract available

PESONEL E, Laouenan C, Guiraud L, Bourner J, et al
Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC).
Clin Infect Dis. 2025 Jan 3:ciae657. doi: 10.1093.
PubMed Abstract available

HUANG YS, Sun HY, Ho SY, Lin KY, et al
Incidence and outcome of hepatitis D virus infection in people with HIV in the era of tenofovir-containing antiretroviral therapy.
Clin Infect Dis. 2025 Jan 2:ciae655. doi: 10.1093.
PubMed Abstract available

December 2024

MONTROUGE T, Bertine M, Peytavin G, Saint Joannis T, et al
Rapid Selection of HIV-2 Capsid Mutations in Salvage Therapy with Lenacapavir-Containing Regimen.
Clin Infect Dis. 2024 Dec 31:ciae650. doi: 10.1093.
PubMed Abstract available

RUFFIEUX Y, Mwansa-Kambafwile J, Metekoua C, Tombe-Nyahuma T, et al
HIV-1 Viremia and Cancer Risk in 2.8 Million People: the South African HIV Cancer Match Study.
Clin Infect Dis. 2024 Dec 30:ciae652. doi: 10.1093.
PubMed Abstract available

PEREZ NAVARRO A, Nutt CT, Siedner MJ, McCluskey SM, et al
Virologic failure and emergent integrase strand transfer inhibitor drug resistance with long acting cabotegravir for HIV treatment: A meta-analysis.
Clin Infect Dis. 2024 Dec 26:ciae631. doi: 10.1093.
PubMed Abstract available

HAN WM, Solomon S, Smeaton L, Avihingsanon A, et al
Reinfection and resistance associated substitutions following a minimal monitoring approach for HCV treatment in MINMON trial.
Clin Infect Dis. 2024 Dec 20:ciae627. doi: 10.1093.
PubMed Abstract available

COUSSEMENT J, Heath CH, Roberts MB, Lane RJ, et al
Management, outcomes and predictors of mortality of Cryptococcus infection in patients without HIV: a multicentre study in 46 hospitals from Australia and New Zealand.
Clin Infect Dis. 2024 Dec 18:ciae630. doi: 10.1093.
PubMed Abstract available

BJORNSON AM, Bedimo RJ, Szabo SM, Rochon H, et al
Morbidity and Mortality Risk Among People With Human Immunodeficiency Virus and Central or Visceral Adiposity: A Targeted Literature Review.
Clin Infect Dis. 2024 Dec 18:ciae543. doi: 10.1093.
PubMed Abstract available

EPLING BP, Lisco A, Manion M, Laidlaw E, et al
Impact of Anti-CD4 Autoantibodies on Immune Reconstitution in People With Advanced Human Immunodeficiency Virus.
Clin Infect Dis. 2024 Dec 18:ciae562. doi: 10.1093.
PubMed Abstract available

KHAN U, Rich M, Franke M, Lachenal N, et al
The Frequency and Incidence of QT Prolongation with Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort.
Clin Infect Dis. 2024 Dec 10:ciae601. doi: 10.1093.
PubMed Abstract available

KAMKWALALA AR, Matthews A, Garg A, Roy U, et al
The Effects of Prescribed Medications on Depressive Symptoms and Neurocognitive Performance in People With Human Immunodeficiency Virus (HIV).
Clin Infect Dis. 2024 Dec 10:ciae518. doi: 10.1093.
PubMed Abstract available

BURMAN WJ, Hawkins KL
Toward Evidence-based Recommendations for Laboratory Monitoring for Adolescents and Adults on Antiretroviral Therapy.
Clin Infect Dis. 2024 Dec 10:ciae542. doi: 10.1093.
PubMed Abstract available

PINANA JL, Carbonell-Asins JA, Gomez D, Montoro J, et al
Community-Acquired Respiratory Virus Infections: A Threat to Long-Term survivors after Allogeneic Stem Cell Transplant?
Clin Infect Dis. 2024 Dec 5:ciae602. doi: 10.1093.
PubMed Abstract available

SWINDELLS S
Bookends.
Clin Infect Dis. 2024 Dec 5:ciae554. doi: 10.1093.
PubMed

November 2024

MAGUIRE C, Rueve K, Farmer E, Huesgen E, et al
Real world virologic outcomes in patients with elevated body mass index receiving long acting cabotegravir/rilpivirine.
Clin Infect Dis. 2024 Nov 27:ciae579. doi: 10.1093.
PubMed Abstract available

FAUCI AS, Folkers GK
HIV/AIDS and COVID-19: Shared Lessons from Two Pandemics.
Clin Infect Dis. 2024 Nov 27:ciae585. doi: 10.1093.
PubMed Abstract available

MOUNZER K, Slim J, Ramgopal M, Hedgcock M, et al
Efficacy and Safety of Switching to Daily Bictegravir Plus Lenacapavir From a Complex Human Immunodeficiency Virus Treatment Regimen: A Randomized, Open-Label, Multicenter Phase 2 Study (ARTISTRY-1).
Clin Infect Dis. 2024 Nov 26:ciae522. doi: 10.1093.
PubMed Abstract available

CLEMENT ME, Hanscom B, Haines D, Bazan JA, et al
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083.
Clin Infect Dis. 2024 Nov 23:ciae572. doi: 10.1093.
PubMed Abstract available

LANZ C, Meier J, Stockle M, Furrer H, et al
HIV-1 low-level viremia predicts viral failure in participants on antiretroviral therapy in the Swiss HIV Cohort Study.
Clin Infect Dis. 2024 Nov 21:ciae569. doi: 10.1093.
PubMed Abstract available

PUYAT JH, Brode SK, Shulha H, Romanowski K, et al
Predicting risk of tuberculosis disease in people migrating to a low-TB incidence country: development and validation of a multivariable dynamic risk prediction model using health administrative data.
Clin Infect Dis. 2024 Nov 20:ciae561. doi: 10.1093.
PubMed Abstract available

ROSEN LV, Thielking AM, Dugdale CM, Montepiedra G, et al
Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and Risks.
Clin Infect Dis. 2024 Nov 15:ciae508. doi: 10.1093.
PubMed Abstract available

DAVIS JM, Rana A, Sax PE, Bares SH, et al
Long-Acting Cabotegravir Plus Rilpivirine in People with HIV with Adherence Challenges and Viremia: Current Data and Future Directions.
Clin Infect Dis. 2024 Nov 12:ciae557. doi: 10.1093.
PubMed Abstract available

PU J, Wu S, He JQ
Efficacy and Safety of Systematic Corticosteroids treatment among HIV-Positive Patients with Tuberculosis: a systematic review and meta-analysis of randomized controlled trials.
Clin Infect Dis. 2024 Nov 11:ciae563. doi: 10.1093.
PubMed Abstract available

JANI IV, Sabi I, Elsbernd K, Meggi B, et al
Impact of point-of-care birth test-and-treat on clinical outcomes among infants with HIV: A cluster randomized trial in Mozambique and Tanzania.
Clin Infect Dis. 2024 Nov 8:ciae530. doi: 10.1093.
PubMed Abstract available

LUO Q, Horner MJ, Haas CB, McGee-Avila JK, et al
Differences in Trends in Cancer Incidence Rates Among People with HIV during 2001-2019 By Race and Ethnicity and By Risk Group in the United States.
Clin Infect Dis. 2024 Nov 7:ciae555. doi: 10.1093.
PubMed Abstract available

DE WAAL R, Wools-Kaloustian K, Brazier E, Althoff KN, et al
Global trends in CD4 count measurement and distribution at first antiretroviral treatment initiation.
Clin Infect Dis. 2024 Nov 6:ciae548. doi: 10.1093.
PubMed Abstract available

ABELMAN RA, Ma Y, Mehta CC, Yang Q, et al
Switch to Integrase Strand Transfer Inhibitors during the Menopausal Transition is Associated with Accelerated Body Composition Change in Women with HIV.
Clin Infect Dis. 2024 Nov 4:ciae540. doi: 10.1093.
PubMed Abstract available

ACHHRA AC, Chan E, Applebaum S, Guerrero M, et al
Five-year evaluation of Anal Cancer Screening Program in Men Who Have Sex With Men with HIV at Two Academic Center Clinics.
Clin Infect Dis. 2024 Nov 4:ciae541. doi: 10.1093.
PubMed Abstract available

SPINELLI MA, Bisom-Rapp E, Heise MJ, Camp C, et al
High Retention and Adherence with Rapid Long-Acting Injectable PrEP Implementation in an Urban Safety-Net Clinic Population.
Clin Infect Dis. 2024 Nov 1:ciae531. doi: 10.1093.
PubMed Abstract available

October 2024

DOMBROWSKI JC, Donnell D, Grabow C, Cohen SE, et al
Evidence-Informed Provision of Doxycycline Post-Exposure Prophylaxis for Prevention of Bacterial Sexually Transmitted Infections.
Clin Infect Dis. 2024 Oct 30:ciae527. doi: 10.1093.
PubMed Abstract available

ORKIN C, Hayes R, Haviland J, Wong YL, et al
Perspectives of people with HIV on implementing long acting cabotegravir plus rilpivirine in clinics and community settings in the UK: results from the anti-sexist, anti-racist, anti-ageist ILANA study.
Clin Infect Dis. 2024 Oct 28:ciae523. doi: 10.1093.
PubMed Abstract available

HORBERG M, Thompson M, Agwu A, Colasanti J, et al
Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America.
Clin Infect Dis. 2024 Oct 12:ciae479. doi: 10.1093.
PubMed Abstract available

VIRDEE AK, Knudtzen FC, Llibre JM, Omland LH, et al
Risk of tuberculosis after achieving HIV virological suppression on antiretroviral therapy: a Danish nationwide prospective cohort study.
Clin Infect Dis. 2024 Oct 8:ciae499. doi: 10.1093.
PubMed Abstract available

MONTANO M, Shapiro AE, Whitney BM, Bamford L, et al
Mpox in People With Human Immunodeficiency Virus: Predictors of Diagnosis, Outcomes, and Vaccine Effectiveness in a Multisite Cohort.
Clin Infect Dis. 2024 Oct 8:ciae464. doi: 10.1093.
PubMed Abstract available

KIRK SE, Young C, Berry H, Hanson R, et al
Comparison of At-Home Versus In-Clinic Receipt of Long-Acting Injectable Cabotegravir/Rilpivirine.
Clin Infect Dis. 2024 Oct 8:ciae472. doi: 10.1093.
PubMed Abstract available

HICKEY MD, Gistand N, Grochowski J, Mayorga-Munoz F, et al
48-week viral suppression rates in people with HIV starting long-acting CAB/RPV with initial viremia.
Clin Infect Dis. 2024 Oct 5:ciae500. doi: 10.1093.
PubMed Abstract available

INZAULE S, Easterbrook P, Latona A, Ford NP, et al
Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis.
Clin Infect Dis. 2024 Oct 3:ciae431. doi: 10.1093.
PubMed Abstract available

September 2024

ROTH AM, Bartholomew TS, Ward KM, Groves A, et al
Preferential Initiation of Long-Acting Injectable Versus Oral HIV Pre-Exposure Prophylaxis Among Women Who Inject Drugs.
Clin Infect Dis. 2024 Sep 30:ciae450. doi: 10.1093.
PubMed Abstract available

FAIRHEAD C, Levi J, Ramesh N, Hill A, et al
Results from systematic review and meta-analysis of the efficacy and safety of two-drug versus three-drug ( Tenofovir/Lamivudine/Dolutegravir; TLD) regimens for HIV treatment.
Clin Infect Dis. 2024 Sep 30:ciae490. doi: 10.1093.
PubMed

FONG Y, Dang L, Zhang B, Fintzi J, et al
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Clin Infect Dis. 2024 Sep 26:ciae465. doi: 10.1093.
PubMed Abstract available

LAHIRI CD, Mehta CC, Yang Q, Maramba T, et al
"Short and Long-term Body Weight Change Following the Switch to or the Addition of Integrase Inhibitors in Persons with HIV Differs by Sex".
Clin Infect Dis. 2024 Sep 26:ciae474. doi: 10.1093.
PubMed Abstract available

BEDIMO R, Hardy D, Lee D, Palella F, et al
Expert Consensus Statement on an Updated Definition of Unintended Weight Loss Among Persons With Human Immunodeficiency Virus in the Modern Treatment Era.
Clin Infect Dis. 2024;79.
PubMed Abstract available

GUTIERREZ F, Fernandez-Gonzalez M, Ledesma C, Losada-Echeberria M, et al
Virological History Predicts Non-sustained Viral Suppression with Long-Acting Cabotegravir and Rilpivirine Therapy, independent of Pharmacokinetic Parameters.
Clin Infect Dis. 2024 Sep 19:ciae475. doi: 10.1093.
PubMed Abstract available

MARTIN-CARMONA J, Corma-Gomez A, Tellez F, Arenga-Barrios D, et al
No impact of HIV coinfection on the mortality in patients with hepatitis C virus infection after sustained virological response.
Clin Infect Dis. 2024 Sep 18:ciae473. doi: 10.1093.
PubMed Abstract available

JOLY V, Ferre VM, Le Hingrat Q, Peytavin G, et al
Immuno-virological and Clinical Follow-up of Persons Living With HIV-2 (PWHIV-2) Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate (BIC/FTC/TAF): A Retrospective Study.
Clin Infect Dis. 2024 Sep 16:ciae447. doi: 10.1093.
PubMed Abstract available

VIDAL JE, Duarte AN, Chow FC, Duarte MIS, et al
Does "Toxoplasma abscess" Properly Describe Brain Lesions Caused by Toxoplasma gondii?
Clin Infect Dis. 2024 Sep 9:ciae463. doi: 10.1093.
PubMed

ANDERSON D, Ramgopal M, Hagins DP, Lee J, et al
DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-based Regimen Switch Strategy to Manage Integrase Inhibitor-related Weight Gain.
Clin Infect Dis. 2024 Sep 4:ciae449. doi: 10.1093.
PubMed Abstract available

EKE AC, Brummel SS, Aliyu MH, Stranix-Chibanda L, et al
Lipid and glucose profiles in pregnant women with HIV on tenofovir-based antiretroviral therapy.
Clin Infect Dis. 2024 Sep 2:ciae441. doi: 10.1093.
PubMed Abstract available

August 2024

GROENENDIJK AL, Miranda Afonso P, Wit F, Blaauw MJT, et al
The risk of non-AIDS defining events is lower in ART-naive HIV controllers than in normal progressors on suppressive ART.
Clin Infect Dis. 2024 Aug 29:ciae440. doi: 10.1093.
PubMed Abstract available

OGBUAGU O, Molina JM, Chetchotisakd P, Ramgopal MN, et al
Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multi-Drug Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial.
Clin Infect Dis. 2024 Aug 29:ciae423. doi: 10.1093.
PubMed Abstract available

BOSMAN S, Ayakaka I, Muhairwe J, Kamele M, et al
Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa.
Clin Infect Dis. 2024 Aug 27:ciae378. doi: 10.1093.
PubMed Abstract available

GAKURU J, Kagimu E, Dai B, Okurut S, et al
Implementation of single high-dose liposomal amphotericin B based induction therapy for treatment of HIV-associated cryptococcal meningitis in Uganda: a comparative prospective cohort study.
Clin Infect Dis. 2024 Aug 24:ciae413. doi: 10.1093.
PubMed Abstract available

ERLANDSON KM, Umbleja T, Ribaudo HJ, Schrack JA, et al
Pitavastatin is Well-Tolerated with no Detrimental Effects on Physical Function.
Clin Infect Dis. 2024 Aug 19:ciae422. doi: 10.1093.
PubMed Abstract available

BERTHAUD V, Creech CB, Rostad CA, Carr Q, et al
Safety and Immunogenicity of an mRNA-1273 Booster in Children.
Clin Infect Dis. 2024 Aug 19:ciae420. doi: 10.1093.
PubMed Abstract available

GRISEL B, Kaur K, Swain S, Gorenshtein L, et al
The Ethical Obligation to Treat Infectious Patients: A Systematic Review of Reasons.
Clin Infect Dis. 2024;79:339-347.
PubMed Abstract available

RUPASINGHE D, Bansi-Matharu L, Law M, Zangerle R, et al
Integrase strand transfer inhibitor (INSTI) related changes in BMI and risk of diabetes: a prospective study from the RESPOND cohort consortium.
Clin Infect Dis. 2024 Aug 9:ciae406. doi: 10.1093.
PubMed Abstract available

July 2024

FRIEDMAN JR, Abramovitz D, Skaathun B, Rangel G, et al
Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study.
Clin Infect Dis. 2024 Jul 30:ciae372. doi: 10.1093.
PubMed Abstract available

BAI AD, Srivastava S, Martinez Cajas JL, Razak F, et al
Community-acquired pneumonia in people with Human Immunodeficiency Virus (HIV) during the current era of effective antiretroviral therapy: A multi-center retrospective cohort study.
Clin Infect Dis. 2024 Jul 27:ciae393. doi: 10.1093.
PubMed Abstract available

DITZENBERGER GL, Lake JE, Kitch DW, Kantor A, et al
Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study.
Clin Infect Dis. 2024 Jul 24:ciae384. doi: 10.1093.
PubMed Abstract available

HIRUY H, Bala S, Byrne JM, Roche KG, et al
FDA, CDC, and NIH Co-sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.
Clin Infect Dis. 2024 Jul 24:ciae386. doi: 10.1093.
PubMed Abstract available

MEYA DB, Nalintya E, Skipper CP, Kirumira P, et al
Adjunctive Single-Dose Liposomal Amphotericin to Prevent Cryptococcal Meningitis in People With Human Immunodeficiency Virus (HIV)-Associated Cryptococcal Antigenemia and Low Plasma Cryptococcal Antigen (CrAg) Titers.
Clin Infect Dis. 2024 Jul 24:ciae266. doi: 10.1093.
PubMed Abstract available

KAUPPINEN KJ, Aho I, Sjoblom N, Tynninen O, et al
Effect of Two Forms of Tenofovir on Duodenal Enterocytes - a Hypothesis for Different Effect of TDF and TAF on Body Weight and Plasma Lipids.
Clin Infect Dis. 2024 Jul 23:ciae374. doi: 10.1093.
PubMed Abstract available

JARRETT BA, Shearer K, Motlhaoleng K, Chon S, et al
Comparison of QuantiFERON Gold In-Tube Versus Tuberculin Skin Tests on the Initiation of Tuberculosis Preventive Therapy Among Patients Newly Diagnosed With Human Immunodeficiency Virus in the North West Province of South Africa (the Teko Study): A Cl
Clin Infect Dis. 2024 Jul 22:ciae268. doi: 10.1093.
PubMed Abstract available

SWARTZ TH, Aberg JA
Collaborative Strategies for Antimicrobial Stewardship Programs: Navigating Financial and Regulatory Landscapes.
Clin Infect Dis. 2024;79:272-273.
PubMed

FIERER DS, Carollo JR, Rodriguez-Caprio G, Radix A, et al
Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New York City.
Clin Infect Dis. 2024 Jul 18:ciae297. doi: 10.1093.
PubMed Abstract available

JILG N, Giganti MJ, Chew KW, Shaw-Saliba K, et al
Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019.
Clin Infect Dis. 2024 Jul 17:ciae324. doi: 10.1093.
PubMed Abstract available

FAIRHEAD C, Levi J, Hill A
Challenges for novel antiretroviral development in an era of widespread TLD availability.
Clin Infect Dis. 2024 Jul 11:ciae361. doi: 10.1093.
PubMed Abstract available

GUTIERREZ F, Lopez L, Galera C, Tiraboschi JM, et al
Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a Comprehensive Cancer Screening Protocol.
Clin Infect Dis. 2024 Jul 3:ciae359. doi: 10.1093.
PubMed Abstract available

MOHAREB AM, Barshak MB, Papaliodis GN, Sobrin L, et al
Ocular syphilis in patients with nonreactive RPR and positive treponemal serologies: a retrospective observational cohort study.
Clin Infect Dis. 2024 Jul 2:ciae354. doi: 10.1093.
PubMed Abstract available

June 2024

KIMUDA S, Kwizera R, Dai B, Kigozi E, et al
Comparison of early fungicidal activity and mortality between daily liposomal amphotericin B and daily amphotericin B deoxycholate among patients with HIV-associated cryptococcal meningitis.
Clin Infect Dis. 2024 Jun 29:ciae326. doi: 10.1093.
PubMed Abstract available

COLLINS LF, Sheth AN, Tisdale T, Mehta CC, et al
Interest in and Preference for Long-acting Injectable Antiretroviral Therapy in the Era of Approved Cabotegravir/Rilpivirine among Reproductive-aged Women in the U.S. South.
Clin Infect Dis. 2024 Jun 29:ciae331. doi: 10.1093.
PubMed Abstract available

FUSCO D, Malenica I, Gunthard HF, Gupta SK, et al
Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison from Two Large, Open-Label Studies.
Clin Infect Dis. 2024 Jun 26:ciae336. doi: 10.1093.
PubMed Abstract available

BORRE ED, Ahonkhai AA, Chi KK, Osman A, et al
Projecting the Potential Clinical and Economic Impact of Human Immunodeficiency Virus Prevention Resource Reallocation in Tennessee.
Clin Infect Dis. 2024 Jun 24:ciae243. doi: 10.1093.
PubMed Abstract available

BROWN L, Rautemaa-Richardson R, Mengoli C, Alanio A, et al
Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis.
Clin Infect Dis. 2024 Jun 11:ciae239. doi: 10.1093.
PubMed Abstract available

TAO G, Patel CG, He L, Workowski K, et al
STI/HIV testing, STIs, and HIV PrEP use among men who have sex with men (MSM) and men who have sex with men and women (MSMW) in United States, 2019-2022.
Clin Infect Dis. 2024 Jun 10:ciae314. doi: 10.1093.
PubMed Abstract available

SKRIVANKOVA VW, Huwa J, Muula G, Chiwaya GD, et al
Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia.
Clin Infect Dis. 2024 Jun 7:ciae261. doi: 10.1093.
PubMed Abstract available

ABBOTT R, Landsiedel K, Atukunda M, Puryear SB, et al
Incident Tuberculosis Infection is Associated with Alcohol use in Adults in Rural Uganda.
Clin Infect Dis. 2024 Jun 2:ciae304. doi: 10.1093.
PubMed Abstract available

May 2024

ALEXANDRE M, Prague M, Lhomme E, Lelievre JD, et al
Definition of Virological Endpoints Improving the Design of Human Immunodeficiency Virus (HIV) Cure Strategies Using Analytical Antiretroviral Treatment Interruption.
Clin Infect Dis. 2024 May 31:ciae235. doi: 10.1093.
PubMed Abstract available

WEDDLE A
Position of the Infectious Diseases Society of America and the HIV Medicine Association on Team-Based Infectious Diseases Care and the Roles of Advanced Practice Providers and Clinical Pharmacists.
Clin Infect Dis. 2024 May 27:ciae265. doi: 10.1093.
PubMed

SAX PE
Team-Based HIV Care is the Best Care.
Clin Infect Dis. 2024 May 24:ciae264. doi: 10.1093.
PubMed

KONU YR, Takassi E, Peytavin G, Dapam N, et al
Pharmaco-virological outcomes and genotypic resistance profiles among children and adolescents receiving a DTG-based regimen in Togo.
Clin Infect Dis. 2024 May 15:ciae278. doi: 10.1093.
PubMed Abstract available

BURKE RM, Nyirenda SK, Mtenga T, Twabi HH, et al
Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial.
Clin Infect Dis. 2024 May 15:ciae273. doi: 10.1093.
PubMed Abstract available

UNIGWE I, Goodin A, Lo-Ciganic WH, Cook RL, et al
Trajectories of Pre-exposure Prophylaxis Adherence Among Commercially Insured Individuals.
Clin Infect Dis. 2024;78:1272-1275.
PubMed Abstract available

CARLUCCI JG, Huntington T, Technau KG, Yotebieng M, et al
High Prevalence of Unconfirmed Positive HIV PCR Test Results among African Infants with HIV Exposure in the International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium.
Clin Infect Dis. 2024 May 14:ciae251. doi: 10.1093.
PubMed Abstract available

SHAH NS, Kityo C, Hughes MD, McCarthy C, et al
Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
Clin Infect Dis. 2024 May 13:ciae269. doi: 10.1093.
PubMed Abstract available

NYEIN PP, Petoumenos K, Borok M, Eriobu N, et al
Associations between antiretroviral regimen and changes in blood pressure: results from the D2EFT study.
Clin Infect Dis. 2024 May 9:ciae256. doi: 10.1093.
PubMed Abstract available

SUN C, Yang Z, Wen Y
Current knowledge about long-term liver outcome among HBV/HIV coinfected patients.
Clin Infect Dis. 2024 May 7:ciae247. doi: 10.1093.
PubMed

VINIKOOR MJ, Lauer GM
People with HBV/HIV coinfection should be prioritized in HBV cure research.
Clin Infect Dis. 2024 May 7:ciae248. doi: 10.1093.
PubMed

SHORT WR, Zimmerman MM, Mohamed O, Mofenson LM, et al
Safety Data Timelines for Pregnant Individuals with HIV on Antiretroviral Therapy.
Clin Infect Dis. 2024 May 6:ciae249. doi: 10.1093.
PubMed Abstract available

ZHANG HL, Mock M, Bushman L, Anderson PL, et al
Cumulative tenofovir exposure among patients with human immunodeficiency virus/hepatitis B co-infection with differential viral suppression.
Clin Infect Dis. 2024 May 3:ciae241. doi: 10.1093.
PubMed Abstract available

VAN DER WEKKEN-PAS L, Weiss F, Simon-Zuber C, Sebisch R, et al
Cabotegravir and rilpivirine long acting injectables in a pregnant woman living with HIV.
Clin Infect Dis. 2024 May 3:ciae242. doi: 10.1093.
PubMed Abstract available

April 2024

HOLT LM, Short WR, Momplaisir F, Hyun E, et al
Bictegravir Use During Pregnancy: A Multi-Center Retrospective Analysis Evaluating HIV Viral Suppression and Perinatal Outcomes.
Clin Infect Dis. 2024 Apr 26:ciae218. doi: 10.1093.
PubMed Abstract available

TUSCH E, Ryom L, Pelchen-Matthews A, Mocroft A, et al
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
Clin Infect Dis. 2024 Apr 26:ciae228. doi: 10.1093.
PubMed Abstract available

ROSENBERG NE, Shook-Sa BE, Young AM, Zou Y, et al
An HIV-1 risk assessment tool for women aged 15-49 in African countries: A pooled analysis across 15 nationally representative surveys.
Clin Infect Dis. 2024 Apr 24:ciae211. doi: 10.1093.
PubMed Abstract available

MWESIGWA B, Sawe F, Oyieko J, Mwakisisile J, et al
Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
Clin Infect Dis. 2024 Apr 24:ciae215. doi: 10.1093.
PubMed Abstract available

COYLE RP, Morrow M, Mann SC, Mainella V, et al
Tenofovir-Diphosphate and Emtricitabine-Triphosphate Adherence Benchmarks in Dried Blood Spots for Persons with HIV Receiving Tenofovir Alafenamide and Emtricitabine-based Antiretroviral Therapy (QUANTI-TAF).
Clin Infect Dis. 2024 Apr 18:ciae212. doi: 10.1093.
PubMed Abstract available

WOHL DA, Koethe JR, Sax PE, McComsey GA, et al
Antiretrovirals and Weight Change: Weighing the Evidence.
Clin Infect Dis. 2024 Apr 12:ciae191. doi: 10.1093.
PubMed Abstract available

DAMAS J, Munting A, Fellay J, Haerry D, et al
Weight, anthropometric and metabolic changes after discontinuing antiretroviral therapy containing tenofovir alafenamide (TAF) in people with HIV.
Clin Infect Dis. 2024 Apr 12:ciae189. doi: 10.1093.
PubMed Abstract available

HILL A
Which form of tenofovir should be used worldwide: TDF or TAF?
Clin Infect Dis. 2024 Apr 12:ciae190. doi: 10.1093.
PubMed

SHERMAN A, Tuan J, Cantos VD, Adeyiga O, et al
COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093.
PubMed Abstract available

BACHELARD A, Le Hingrat Q, Ferre VM, Le M, et al
Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human Immunodeficiency Virus Type 2 Infection.
Clin Infect Dis. 2024;78:1005-1010.
PubMed Abstract available

CHABALA C, Wobudeya E, van der Zalm MM, Kapasa M, et al
Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093.
PubMed Abstract available

CACHAY ER, Gilbert T, Qin H, Mathews WC, et al
Clinical Predictors and Outcomes of Invasive Anal Cancer for People With Human Immunodeficiency Virus in an Inception Cohort.
Clin Infect Dis. 2024 Apr 4:ciae124. doi: 10.1093.
PubMed Abstract available

RODRIGUEZ-MOLINO P, Tebruegge M, Noguera-Julian A, Neth O, et al
Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study.
Clin Infect Dis. 2024 Apr 3:ciae158. doi: 10.1093.
PubMed Abstract available

PODANY AT, Cramer Y, Imperial M, Rosenkranz SL, et al
Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily Rifapentine and Isoniazid (1HP) for TB Prevention.
Clin Infect Dis. 2024 Apr 3:ciae183. doi: 10.1093.
PubMed Abstract available

TSCHUMI N, Lukau B, Tlali K, Motaboli L, et al
Emergence of acquired dolutegravir resistance in treatment-experienced people with HIV in Lesotho.
Clin Infect Dis. 2024 Apr 3:ciae185. doi: 10.1093.
PubMed Abstract available

FAHERTY EAG, Holly T, Ogale YP, Spencer H, et al
Investigation of an mpox outbreak affecting many vaccinated persons in Chicago, IL-March 2023-June 2023.
Clin Infect Dis. 2024 Apr 3:ciae181. doi: 10.1093.
PubMed Abstract available

March 2024

ROSTAD CA, Atmar RL, Walter EB, Frey S, et al
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US
Clin Infect Dis. 2024 Mar 27:ciae173. doi: 10.1093.
PubMed Abstract available

BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
PubMed Abstract available

JAO J, Bonner LB, Dobinda K, Powis KM, et al
Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study.
Clin Infect Dis. 2024 Mar 26:ciae088. doi: 10.1093.
PubMed Abstract available

VALIN N, Lambert-Niclot S, Torres E, Meynard JL, et al
A Human Immunodeficiency Virus Superinfection Diagnosed in a Patient on Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine.
Clin Infect Dis. 2024 Mar 21:ciad757. doi: 10.1093.
PubMed Abstract available

BOODMAN C, Gupta N, Nelson CA, van Griensven J, et al
Bartonella quintana Endocarditis: A Systematic Review of Individual Cases.
Clin Infect Dis. 2024;78:554-561.
PubMed Abstract available

KRISHNAN S, Chaisson RE
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
Clin Infect Dis. 2024;78:514-517.
PubMed Abstract available

VANBAELEN T, Tsoumanis A, Kenyon C
Total Antimicrobial Consumption in Doxycycline Postexposure Prophylaxis Cohorts and the Intensity of Screening for Bacterial Sexually Transmitted Infections.
Clin Infect Dis. 2024;78:803-805.
PubMed

NGUYEN Q, Wooten D, Lee D, Moreno M, et al
GLP-1 Receptor Agonists Promote Weight Loss Among People with HIV.
Clin Infect Dis. 2024 Mar 19:ciae151. doi: 10.1093.
PubMed Abstract available

HAZRA A, Celum C, Luetkemeyer AF, Molina JM, et al
Risk of antimicrobial resistance with doxy-PEP is real, as is the need for its well-Informed implementation.
Clin Infect Dis. 2024 Mar 19:ciae152. doi: 10.1093.
PubMed

KENYON C
We should not downplay the risks that doxycycline PEP will select for AMR.
Clin Infect Dis. 2024 Mar 19:ciae139. doi: 10.1093.
PubMed

LANDOVITZ RJ, Tao L, Yang J, de Boer M, et al
HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Analysis From 72 Global Studies.
Clin Infect Dis. 2024 Mar 14:ciae143. doi: 10.1093.
PubMed Abstract available

MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
The positioning of ceftobiprole in the treatment of Staphylococcus aureus bacteremia.
Clin Infect Dis. 2024 Mar 11:ciae126. doi: 10.1093.
PubMed

NGO HX, Xu AY, Velasquez GE, Zhang N, et al
Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
Clin Infect Dis. 2024 Mar 11:ciae119. doi: 10.1093.
PubMed Abstract available

February 2024

CROCKER-BUQUE T, Lachenal N, Narasimooloo C, Abdrasuliev T, et al
Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
Clin Infect Dis. 2024 Feb 29:ciad767. doi: 10.1093.
PubMed

TEIXEIRA LAA, Santos B, Correia MG, Valiquette C, et al
Long-term protective effect of tuberculosis preventive therapy in a medium/high TB incidence setting.
Clin Infect Dis. 2024 Feb 26:ciae101. doi: 10.1093.
PubMed Abstract available

SALDANA CS, Burkhardt E, Pennisi A, Oliver K, et al
Development of a Machine Learning Modelling Tool for Predicting HIV Incidence Using Public Health Data from a County in the Southern United States.
Clin Infect Dis. 2024 Feb 23:ciae100. doi: 10.1093.
PubMed Abstract available

FOLLMANN D, Mateja A, Fay MP, Magaret CA, et al
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.
Clin Infect Dis. 2024 Feb 19:ciae081. doi: 10.1093.
PubMed Abstract available

January 2024

LITWIN AH, Akiyama MJ
US Veterans Health Administration Hepatitis C Virus (HCV) Program - A Model for National HCV Elimination though Patient-Centered Medical Homes.
Clin Infect Dis. 2024 Jan 27:ciae028. doi: 10.1093.
PubMed

YATES TA, Halliday N
Re: Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver Transplant Reci
Clin Infect Dis. 2024 Jan 9:ciae004. doi: 10.1093.
PubMed

November 2023

HERBERT C, Manabe YC, Filippaios A, Lin H, et al
Differential Viral Dynamics by Sex and Body Mass Index During Acute SARS-CoV-2 Infection: Results from a Longitudinal Cohort Study.
Clin Infect Dis. 2023 Nov 16:ciad701. doi: 10.1093.
PubMed Abstract available

October 2023

SEMPERE A, Assoumou L, Gonzalez-Cordon A, Waters L, et al
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-02
Clin Infect Dis. 2023;77:991-1009.
PubMed Abstract available

May 2023

AHSBERG J, Puplampu P, Kwashie A, Commey JO, et al
Point-of-care urine LAM testing to guide tuberculosis treatment among severely ill in-patients with HIV in real-world practice: a multi-center stepped wedge cluster-randomized trial from Ghana.
Clin Infect Dis. 2023 May 26:ciad316. doi: 10.1093.
PubMed Abstract available

September 2022

BHIMRAJ A, Morgan RL, Shumaker AH, Baden L, et al
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
Clin Infect Dis. 2022 Sep 5. pii: 6692369. doi: 10.1093.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum